Role	O
of	O
EGR1	B-protein
in	O
regulation	O
of	O
stimulus-dependent	O
CD44	B-protein
transcription	O
in	O
B	O
lymphocytes	O
.	O

The	O
immediate-early	B-DNA
gene	I-DNA
egr-1	B-DNA
encodes	O
a	O
transcription	B-protein
factor	I-protein
(	O
EGR1	B-protein
)	O
that	O
links	O
B-cell	B-protein
antigen	I-protein
receptor	I-protein
(	O
BCR	B-protein
)	O
signals	O
to	O
downstream	O
activation	O
events	O
through	O
the	O
regulation	O
of	O
previously	O
unidentified	O
target	B-DNA
genes	I-DNA
.	O

Here	O
we	O
identify	O
the	O
gene	O
encoding	O
the	O
lymphocyte	B-protein
homing	I-protein
and	I-protein
migration	I-protein
protein	I-protein
CD44	B-protein
as	O
a	O
target	O
of	O
EGR1	B-protein
regulation	O
in	O
B	B-cell_type
cells	I-cell_type
.	O

BCR	B-protein
-induced	O
increases	O
in	O
CD44	B-RNA
mRNA	I-RNA
expression	O
and	O
transcription	O
levels	O
are	O
shown	O
to	O
occur	O
in	O
EGR1-expressing	B-cell_line
but	I-cell_line
not	I-cell_line
in	I-cell_line
nonexpressing	I-cell_line
subclones	I-cell_line
of	O
the	O
B-cell	B-cell_line
line	I-cell_line
WEHI-231	B-cell_line
.	O

Kinetics	O
of	O
egr-1	B-DNA
transcription	O
and	O
the	O
appearance	O
of	O
nuclear	O
EGR1	B-protein
protein	I-protein
precede	O
CD44	B-protein
induction	O
and	O
occur	O
within	O
30	O
min	O
after	O
stimulation	O
in	O
the	O
EGR1-expressing	B-cell_line
subclone	I-cell_line
.	O

A	O
single	O
EGR1	B-protein
binding	O
motif	O
is	O
demonstrated	O
at	O
bp	O
-301	O
of	O
the	O
human	B-DNA
CD44	I-DNA
promoter	I-DNA
.	O

Cotransfection	O
of	O
a	O
CD44	B-DNA
promoter-chloramphenicol	I-DNA
acetyltransferase	I-DNA
reporter	I-DNA
construct	I-DNA
with	O
an	O
egr-1	B-DNA
expression	I-DNA
vector	I-DNA
resulted	O
in	O
a	O
6.5-	O
to	O
8.5-fold	O
induction	O
of	O
transcriptional	O
activity	O
relative	O
to	O
an	O
empty	B-DNA
expression	I-DNA
vector	I-DNA
.	O

The	O
EGR1	B-DNA
binding	I-DNA
motif	I-DNA
was	O
shown	O
to	O
be	O
necessary	O
for	O
stimulus-induced	O
expression	O
of	O
a	O
CD44	B-protein
promoter-chloramphenicol	B-DNA
acetyltransferase	I-DNA
reporter	I-DNA
construct	I-DNA
in	O
nontransformed	B-cell_type
B	I-cell_type
lymphocytes	I-cell_type
and	O
was	O
required	O
for	O
transactivation	O
by	O
an	O
EGR1	B-DNA
expression	I-DNA
vector	I-DNA
in	O
a	O
B-cell	B-cell_line
line	I-cell_line
.	O

These	O
studies	O
identify	O
EGR1	B-protein
as	O
an	O
intermediary	O
linking	O
BCR	B-protein
-derived	O
signals	O
to	O
the	O
induction	O
of	O
CD44	B-protein
.	O

The	O
relevance	O
of	O
these	O
molecular	O
events	O
to	O
BCR	B-protein
signal	O
transduction	O
and	O
antigen-stimulated	O
B-cell-mediated	O
immune	O
responses	O
is	O
discussed	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLOGY	NULL
,	NULL
May	NULL
1996	NULL
,	NULL
p.	NULL
2283-2294	NULL
0270-7306/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
Â©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

16	NULL
,	NULL
No	NULL
.	NULL

5	NULL
Role	NULL
of	NULL
EGR1	NULL
in	NULL
Regulation	NULL
of	NULL
Stimulus-Dependent	NULL
CD44	NULL
Transcription	NULL
in	NULL
B	NULL
Lymphocytes	NULL
JONATHAN	NULL
S	NULL
$	NULL
.	NULL

MALTZMAN	NULL
,	NULL
JULIE	NULL
A.	NULL
CARMAN	NULL
,	NULL
anp	NULL
JOHN	NULL
G.	NULL
MONROE*	NULL
Department	NULL
of	NULL
Pathology	NULL
and	NULL
Laboratory	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
Pennsylvania	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Philadelphia	NULL
,	NULL
Pennsylvania	NULL
19104	NULL
Received	NULL
14	NULL
September	NULL
1995/Returned	NULL
for	NULL
modification	NULL
27	NULL
October	NULL
1995/Accepted	NULL
22	NULL
February	NULL
1996	NULL
The	NULL
immediate-early	NULL
gene	NULL
egr-1	NULL
encodes	NULL
a	NULL
transcription	NULL
factor	NULL
(	NULL
EGR1	NULL
)	NULL
that	NULL
links	NULL
B-cell	NULL
antigen	NULL
receptor	NULL
(	NULL
BCR	NULL
)	NULL
signals	NULL
to	NULL
downstream	NULL
activation	NULL
events	NULL
through	NULL
the	NULL
regulation	NULL
of	NULL
previously	NULL
unidentified	NULL
target	NULL
genes	NULL
.	NULL

Here	NULL
we	NULL
identify	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
lymphocyte	NULL
homing	NULL
and	NULL
migration	NULL
protein	NULL
CD44	NULL
as	NULL
a	NULL
target	NULL
of	NULL
EGR1	NULL
regulation	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

BCR-induced	NULL
increases	NULL
in	NULL
CD44	NULL
mRNA	NULL
expression	NULL
and	NULL
transcription	NULL
levels	NULL
are	NULL
shown	NULL
to	NULL
occur	NULL
in	NULL
EGR1-expressing	NULL
but	NULL
not	NULL
in	NULL
nonexpressing	NULL
subclones	NULL
of	NULL
the	NULL
B-cell	NULL
line	NULL
WEHI-231	NULL
.	NULL

Kinetics	NULL
of	NULL
egr-1	NULL
transcription	NULL
and	NULL
the	NULL
appearance	NULL
of	NULL
nuclear	NULL
EGR1	NULL
protein	NULL
precede	NULL
CD44	NULL
induction	NULL
and	NULL
occur	NULL
within	NULL
30	NULL
min	NULL
after	NULL
stimulation	NULL
in	NULL
the	NULL
EGR1-expressing	NULL
subclone	NULL
.	NULL

A	NULL
single	NULL
EGR1	NULL
binding	NULL
motif	NULL
is	NULL
demonstrated	NULL
at	NULL
bp	NULL
-301	NULL
of	NULL
the	NULL
human	NULL
CD44	NULL
promoter	NULL
.	NULL

Cotransfection	NULL
of	NULL
a	NULL
CD44	NULL
promoter-chloramphenicol	NULL
acetyltransferase	NULL
reporter	NULL
construct	NULL
with	NULL
an	NULL
egr-1	NULL
expression	NULL
vector	NULL
resulted	NULL
in	NULL
a	NULL
6.5-	NULL
to	NULL
8.5-fold	NULL
induction	NULL
of	NULL
transcriptional	NULL
activity	NULL
relative	NULL
to	NULL
an	NULL
empty	NULL
expression	NULL
vector	NULL
.	NULL

The	NULL
EGR1	NULL
binding	NULL
motif	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
stimulus-induced	NULL
expression	NULL
of	NULL
a	NULL
CD44	NULL
promoter-chloramphenicol	NULL
acetyltransferase	NULL
reporter	NULL
construct	NULL
in	NULL
nontransformed	NULL
B	NULL
lymphocytes	NULL
and	NULL
was	NULL
required	NULL
for	NULL
transactivation	NULL
by	NULL
an	NULL
EGR1	NULL
expression	NULL
vector	NULL
in	NULL
a	NULL
B-cell	NULL
line	NULL
.	NULL

These	NULL
studies	NULL
identify	NULL
EGR1	NULL
as	NULL
an	NULL
intermediary	NULL
linking	NULL
BCR-derived	NULL
signals	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
CD44	NULL
.	NULL

The	NULL
relevance	NULL
of	NULL
these	NULL
molecular	NULL
events	NULL
to	NULL
BCR	NULL
signal	NULL
transduction	NULL
and	NULL
antigen-stimulated	NULL
B-cell-mediated	NULL
immune	NULL
responses	NULL
is	NULL
discussed	NULL
.	NULL

In	NULL
vivo	NULL
,	NULL
antigenic	NULL
stimulation	NULL
of	NULL
mature	NULL
B	NULL
lymphocytes	NULL
initiates	NULL
processes	NULL
leading	NULL
to	NULL
alterations	NULL
in	NULL
cell	NULL
surface	NULL
pheno-type	NULL
,	NULL
migration	NULL
and	NULL
adhesion	NULL
,	NULL
clonal	NULL
proliferation	NULL
and	NULL
,	NULL
ulti-mately	NULL
,	NULL
differentiation	NULL
into	NULL
memory	NULL
and	NULL
antibody-secreting	NULL
plasma	NULL
cells	NULL
.	NULL

An	NULL
approach	NULL
to	NULL
understanding	NULL
the	NULL
underlying	NULL
molecular	NULL
basis	NULL
for	NULL
these	NULL
changes	NULL
has	NULL
been	NULL
to	NULL
study	NULL
signal	NULL
transduction	NULL
events	NULL
associated	NULL
with	NULL
cross-linking	NULL
of	NULL
the	NULL
B-cell	NULL
antigen	NULL
receptor	NULL
(	NULL
BCR	NULL
)	NULL
of	NULL
mature	NULL
B	NULL
lymphocytes	NULL
.	NULL

It	NULL
is	NULL
well	NULL
established	NULL
that	NULL
BCR	NULL
cross-linking	NULL
leads	NULL
to	NULL
alterations	NULL
in	NULL
biochemical	NULL
second	NULL
messengers	NULL
(	NULL
4	NULL
)	NULL
followed	NULL
by	NULL
the	NULL
induction	NULL
of	NULL
immediate-early-gene-encoded	NULL
transcription	NULL
factors	NULL
(	NULL
28	NULL
,	NULL
39	NULL
,	NULL
42	NULL
)	NULL
;	NULL
the	NULL
latter	NULL
are	NULL
thought	NULL
to	NULL
function	NULL
by	NULL
translating	NULL
second-messenger	NULL
pathways	NULL
into	NULL
relevant	NULL
B-cell	NULL
responses	NULL
through	NULL
the	NULL
coordinate	NULL
regulation	NULL
of	NULL
secondary	NULL
(	NULL
delayed	NULL
)	NULL
response	NULL
genes	NULL
(	NULL
35	NULL
)	NULL
.	NULL

CD44	NULL
(	NULL
Pgp-1	NULL
)	NULL
is	NULL
a	NULL
cell	NULL
surface	NULL
glycoprotein	NULL
expressed	NULL
on	NULL
multiple	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
both	NULL
B	NULL
and	NULL
T	NULL
lymphocytes	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Cell	NULL
surface	NULL
levels	NULL
are	NULL
upregulated	NULL
on	NULL
murine	NULL
B	NULL
lymphocytes	NULL
following	NULL
stimulation	NULL
through	NULL
the	NULL
BCR	NULL
(	NULL
5	NULL
)	NULL
.	NULL

CD44	NULL
has	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
the	NULL
cellular	NULL
receptor	NULL
for	NULL
hyaluronic	NULL
acid	NULL
(	NULL
HA	NULL
)	NULL
(	NULL
2	NULL
,	NULL
40	NULL
,	NULL
63	NULL
)	NULL
.	NULL

Binding	NULL
to	NULL
HA	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
migration	NULL
of	NULL
lymphocytes	NULL
to	NULL
and	NULL
their	NULL
retention	NULL
in	NULL
peripheral	NULL
lymphoid	NULL
tissues	NULL
(	NULL
45	NULL
)	NULL
.	NULL

BCR-induced	NULL
changes	NULL
in	NULL
CD44	NULL
expression	NULL
(	NULL
44	NULL
)	NULL
and	NULL
posttranslational	NULL
modification	NULL
(	NULL
22	NULL
,	NULL
27	NULL
,	NULL
32	NULL
)	NULL
are	NULL
proposed	NULL
to	NULL
facilitate	NULL
B-cell	NULL
migration	NULL
to	NULL
and	NULL
retention	NULL
in	NULL
secondary	NULL
lymphoid	NULL
organs	NULL
where	NULL
they	NULL
then	NULL
encounter	NULL
and	NULL
receive	NULL
secondary	NULL
activation	NULL
signals	NULL
from	NULL
T	NULL
helper	NULL
cells	NULL
.	NULL

The	NULL
immediate-early	NULL
gene	NULL
egr-1	NULL
(	NULL
60	NULL
,	NULL
61	NULL
)	NULL
(	NULL
also	NULL
known	NULL
as	NULL
NGFI-A	NULL
[	NULL
38	NULL
]	NULL
,	NULL
Krox-24	NULL
[	NULL
30	NULL
]	NULL
,	NULL
and	NULL
Zif268	NULL
[	NULL
13	NULL
]	NULL
)	NULL
encodes	NULL
a	NULL
nuclear	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Pathology	NULL
and	NULL
Laboratory	NULL
Medicine	NULL
,	NULL
Room	NULL
538A	NULL
,	NULL
Clinical	NULL
Research	NULL
Building	NULL
,	NULL
415	NULL
Curie	NULL
Blvd	NULL
.	NULL

,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
19104	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
215	NULL
)	NULL
898-2873	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
215	NULL
)	NULL
573-2014	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
MonroeJ	NULL
@	NULL
mail.med.upenn	NULL
.edu	NULL
.	NULL

2283	NULL
protein	NULL
(	NULL
EGR1	NULL
)	NULL
that	NULL
is	NULL
the	NULL
prototypic	NULL
member	NULL
of	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
sharing	NULL
a	NULL
conserved	NULL
zinc	NULL
finger	NULL
DNA	NULL
binding	NULL
motif	NULL
(	NULL
6	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
proteins	NULL
bind	NULL
with	NULL
high	NULL
affinity	NULL
to	NULL
the	NULL
consensus	NULL
9-bp	NULL
site	NULL
5'-GCG	NULL
(	NULL
T/G	NULL
)	NULL
GG	NULL
GCG-3	NULL
'	NULL
(	NULL
12	NULL
,	NULL
31	NULL
)	NULL
,	NULL
binding	NULL
to	NULL
motifs	NULL
differing	NULL
in	NULL
1	NULL
or	NULL
2	NULL
bp	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
(	NULL
41	NULL
,	NULL
49	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
flanking	NULL
sequences	NULL
can	NULL
have	NULL
an	NULL
effect	NULL
on	NULL
binding	NULL
affinity	NULL
(	NULL
62	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
egr-1	NULL
expression	NULL
is	NULL
induced	NULL
within	NULL
30	NULL
min	NULL
following	NULL
BCR	NULL
cross-linking	NULL
of	NULL
splenic	NULL
B	NULL
lymphocytes	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Studies	NULL
using	NULL
antisense	NULL
oligonucleotides	NULL
have	NULL
suggested	NULL
that	NULL
egr-1	NULL
expression	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
in	NULL
vitro	NULL
activation	NULL
of	NULL
murine	NULL
splenic	NULL
B	NULL
lymphocytes	NULL
in	NULL
response	NULL
to	NULL
BCR	NULL
cross-linking	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
EGR1	NULL
protein	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
transcriptional	NULL
activator	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
8	NULL
)	NULL
as	NULL
well	NULL
as	NULL
other	NULL
cells	NULL
(	NULL
17	NULL
,	NULL
51	NULL
)	NULL
,	NULL
and	NULL
its	NULL
role	NULL
in	NULL
BCR-initiated	NULL
responses	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
due	NULL
to	NULL
its	NULL
ability	NULL
to	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
specific	NULL
activation-associated	NULL
genes	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
CD44	NULL
5	NULL
``	NULL
flanking	NULL
region	NULL
identified	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
potential	NULL
EGR1	NULL
binding	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
proposed	NULL
transcription	NULL
start	NULL
site	NULL
of	NULL
this	NULL
gene	NULL
.	NULL

Our	NULL
unpublished	NULL
data	NULL
(	NULL
now	NULL
shown	NULL
herein	NULL
)	NULL
revealed	NULL
an	NULL
increase	NULL
in	NULL
CD44	NULL
message	NULL
levels	NULL
between	NULL
2	NULL
and	NULL
4	NULL
h	NULL
after	NULL
BCR	NULL
stimulation	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
kinetics	NULL
of	NULL
induction	NULL
of	NULL
the	NULL
CD44	NULL
gene	NULL
are	NULL
consistent	NULL
with	NULL
its	NULL
being	NULL
among	NULL
the	NULL
class	NULL
of	NULL
delayed	NULL
response	NULL
genes	NULL
in	NULL
BCR-initiated	NULL
B-cell	NULL
responses	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
induction	NULL
of	NULL
CD44	NULL
by	NULL
BCR	NULL
cross-linking	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
potential	NULL
EGR1	NULL
binding	NULL
sites	NULL
suggested	NULL
the	NULL
possibility	NULL
that	NULL
CD44	NULL
transcription	NULL
is	NULL
regulated	NULL
by	NULL
EGR1	NULL
during	NULL
BCR	NULL
signaling	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
role	NULL
of	NULL
EGR1	NULL
in	NULL
regulating	NULL
CD44	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
BCR	NULL
signaling	NULL
and	NULL
a	NULL
pharmacologic	NULL
agent	NULL
(	NULL
the	NULL
phorbol	NULL
ester	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
[	NULL
PMA	NULL
]	NULL
)	NULL
which	NULL
mimics	NULL
specific	NULL
aspects	NULL
of	NULL
BCR	NULL
signal	NULL
transduction	NULL
.	NULL

Our	NULL
studies	NULL
indicate	NULL
that	NULL
CD44	NULL
is	NULL
a	NULL
target	NULL
gene	NULL
of	NULL
EGR1	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
suggest	NULL
that	NULL
EGR1	NULL
acts	NULL
to	NULL
link	NULL
BCR-mediated	NULL
signals	NULL
to	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
a	NULL
mediator	NULL
of	NULL
B-cell	NULL
migration	NULL
and	NULL
homing	NULL
.	NULL

2284	NULL
MALTZMAN	NULL
ET	NULL
AL	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
and	NULL
isolation	NULL
of	NULL
murine	NULL
B	NULL
lymphocytes	NULL
.	NULL

The	NULL
WEHI-231	NULL
B-cell	NULL
lymphoma	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
and	NULL
the	NULL
limiting	NULL
dilution	NULL
subclones	NULL
WEHI-231.7	NULL
and	NULL
WEHI-231.1F1	NULL
(	NULL
hereafter	NULL
referred	NULL
to	NULL
as	NULL
231.7	NULL
and	NULL
1F1	NULL
,	NULL
respectively	NULL
)	NULL
were	NULL
maintained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
,	NULL
high	NULL
glucose	NULL
,	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
defined	NULL
;	NULL
Hyclone	NULL
)	NULL
,	NULL
SerExtend	NULL
(	NULL
Hana	NULL
Biologicals	NULL
,	NULL
Berkeley	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
3	NULL
mM	NULL
1-glutamine	NULL
,	NULL
and	NULL
5	NULL
x	NULL
10~*	NULL
M	NULL
2-mer-captocthanol	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
at	NULL
a	NULL
minimum	NULL
and	NULL
maximum	NULL
density	NULL
of	NULL
1	NULL
10	NULL
%	NULL
and	NULL
5	NULL
X	NULL
10Â°	NULL
per	NULL
ml	NULL
,	NULL
respectively	NULL
.	NULL

B	NULL
lymphocytes	NULL
were	NULL
isolated	NULL
from	NULL
spleens	NULL
of	NULL
BALB/c	NULL
mice	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
37	NULL
)	NULL
,	NULL
Briefly	NULL
,	NULL
spleens	NULL
were	NULL
ground	NULL
between	NULL
the	NULL
frosted	NULL
ends	NULL
of	NULL
two	NULL
glass	NULL
slides	NULL
to	NULL
produce	NULL
single-cell	NULL
suspensions	NULL
.	NULL

Following	NULL
the	NULL
depletion	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
treatment	NULL
with	NULL
anti-Thy1.2	NULL
antibody	NULL
and	NULL
complement	NULL
and	NULL
erythrocytes	NULL
by	NULL
lysis	NULL
with	NULL
Grey	NULL
's	NULL
solution	NULL
,	NULL
the	NULL
remaining	NULL
cell	NULL
suspension	NULL
was	NULL
centrifuged	NULL
over	NULL
a	NULL
75	NULL
%	NULL
Percoll	NULL
cushion	NULL
and	NULL
the	NULL
interface	NULL
was	NULL
collected	NULL
.	NULL

This	NULL
treatment	NULL
results	NULL
in	NULL
a	NULL
population	NULL
of	NULL
>	NULL
90	NULL
%	NULL
immunoglobulin	NULL
M-positive	NULL
(	NULL
IgM	NULL
*	NULL
)	NULL
B220*	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
incubated	NULL
at	NULL
37Â°C	NULL
,	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
,	NULL
for	NULL
72	NULL
h	NULL
in	NULL
B-cell	NULL
assay	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
OPI	NULL
supplement	NULL
[	NULL
Gibco	NULL
BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Md	NULL
.	NULL
]	NULL

,	NULL
nonessential	NULL
amino	NULL
acids	NULL
[	NULL
Gibco	NULL
BRL	NULL
]	NULL
,	NULL
100	NULL
pg	NULL
of	NULL
penicillin	NULL
per	NULL
ml	NULL
,	NULL
100	NULL
ug	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
5	NULL
x	NULL
10~5	NULL
2-mercapto-ethanol	NULL
)	NULL
and	NULL
50	NULL
pg	NULL
of	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
.	NULL

Plasmids	NULL
,	NULL
constructs	NULL
,	NULL
and	NULL
probes	NULL
.	NULL

pAC-mEGR1	NULL
,	NULL
containing	NULL
the	NULL
murine	NULL
egr-1	NULL
cDNA	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
B-actin	NULL
promoter	NULL
,	NULL
was	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
D.	NULL
Licbermann	NULL
(	NULL
Temple	NULL
University	NULL
)	NULL
(	NULL
46	NULL
)	NULL
.	NULL

pAC	NULL
was	NULL
constructed	NULL
by	NULL
excision	NULL
of	NULL
egr-1	NULL
from	NULL
pAC-mEGR1	NULL
with	NULL
Seil	NULL
and	NULL
BamHI	NULL
;	NULL
this	NULL
was	NULL
followed	NULL
by	NULL
blunt-end	NULL
generation	NULL
with	NULL
Klenow	NULL
polymerase	NULL
and	NULL
religation	NULL
.	NULL

pAC-hEGR1	NULL
was	NULL
constructed	NULL
by	NULL
subcloning	NULL
a	NULL
1.7-kb	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
egr-1	NULL
cDNA	NULL
from	NULL
H-364	NULL
(	NULL
59	NULL
)	NULL
into	NULL
the	NULL
Sell-BamHI	NULL
site	NULL
of	NULL
pHB-Actin-polyAneo	NULL
(	NULL
19	NULL
)	NULL
.	NULL

rlep1	NULL
,	NULL
containing	NULL
the	NULL
full-length	NULL
CD44	NULL
cDNA	NULL
,	NULL
was	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
E.	NULL
PurÃ©	NULL
(	NULL
5	NULL
)	NULL
.	NULL

pBlueCD44	NULL
was	NULL
constructed	NULL
by	NULL
subcloning	NULL
a	NULL
1.3-kb	NULL
HindIII-NofI	NULL
fragment	NULL
containing	NULL
the	NULL
entire	NULL
CD44	NULL
cDNA	NULL
into	NULL
pBluescript	NULL
SK+	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

pGAPDH	NULL
,	NULL
containing	NULL
a	NULL
1.2-kb	NULL
glyceraldehyde	NULL
3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
insert	NULL
in	NULL
pBluescript	NULL
SK+	NULL
,	NULL
was	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
M.	NULL
Prystowski	NULL
(	NULL
Albert	NULL
Einstein	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Bronx	NULL
,	NULL
N.Y.	NULL
)	NULL
.	NULL

pBlueEGRA3	NULL
'	NULL
,	NULL
containing	NULL
the	NULL
egr-1	NULL
region	NULL
between	NULL
bp	NULL
1	NULL
and	NULL
1246	NULL
,	NULL
was	NULL
constructed	NULL
by	NULL
subcloning	NULL
of	NULL
the	NULL
3.1-kb	NULL
murine	NULL
egr-1	NULL
cDNA	NULL
into	NULL
the	NULL
EcoRI	NULL
site	NULL
of	NULL
pBluescript	NULL
SK+	NULL
followed	NULL
by	NULL
digestion	NULL
with	NULL
BermHI	NULL
and	NULL
Ndel	NULL
,	NULL
blunt-end	NULL
generation	NULL
,	NULL
and	NULL
religation	NULL
.	NULL

pSacBCAT	NULL
,	NULL
containing	NULL
bp	NULL
-701	NULL
to	NULL
-42	NULL
of	NULL
the	NULL
human	NULL
CD44	NULL
promoter	NULL
fused	NULL
upstream	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
gene	NULL
was	NULL
provided	NULL
by	NULL
E.	NULL
Shtivelman	NULL
(	NULL
57	NULL
)	NULL
.	NULL

The	NULL
region	NULL
encompassing	NULL
-701	NULL
to	NULL
-151	NULL
was	NULL
excised	NULL
with	NULL
HindIII	NULL
and	NULL
Psfl	NULL
and	NULL
subcloned	NULL
into	NULL
pBluescript	NULL
SK+	NULL
(	NULL
Strategene	NULL
)	NULL
.	NULL

A	NULL
HindIII-BamHI	NULL
fragment	NULL
was	NULL
then	NULL
subcloned	NULL
into	NULL
HindIII-BamHI-digested	NULL
pBLCAT2	NULL
(	NULL
18	NULL
)	NULL
to	NULL
generate	NULL
the	NULL
reporter	NULL
construct	NULL
pBLCD44	NULL
.	NULL

For	NULL
construction	NULL
of	NULL
pBLimCD44	NULL
,	NULL
splicing	NULL
overlap	NULL
PCR	NULL
(	NULL
25	NULL
)	NULL
was	NULL
used	NULL
to	NULL
mutate	NULL
the	NULL
EGR1	NULL
binding	NULL
motif	NULL
at	NULL
bp	NULL
-301	NULL
.	NULL

The	NULL
oligonucleotides	NULL
used	NULL
were	NULL
5	NULL
``	NULL
-CACGGGGCGGGTCTA	NULL
GAGGG-3	NULL
'	NULL
and	NULL
its	NULL
reverse	NULL
complement	NULL
.	NULL

Presence	NULL
of	NULL
the	NULL
mutation	NULL
was	NULL
confirmed	NULL
by	NULL
sequencing	NULL
with	NULL
a	NULL
Sequenase	NULL
2.0	NULL
kit	NULL
(	NULL
U.S.	NULL
Biochemicals	NULL
,	NULL
Cleveland	NULL
,	NULL
Ohio	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

pSV	NULL
,	NULL
APAP	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
T.	NULL
Kadesch	NULL
,	NULL
University	NULL
of	NULL
Pennsylvania	NULL
)	NULL
contains	NULL
the	NULL
gene	NULL
for	NULL
the	NULL
placental	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
PAP	NULL
)	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
a	NULL
constitutive	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
(	NULL
23	NULL
)	NULL
.	NULL

pBLET-ERE	NULL
contains	NULL
a	NULL
single	NULL
EBS	NULL
cloned	NULL
into	NULL
the	NULL
Seil	NULL
site	NULL
of	NULL
pBLCAT2	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Antibodies	NULL
for	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
analysis	NULL
.	NULL

Analysis	NULL
for	NULL
relative	NULL
IgM	NULL
,	NULL
IgD	NULL
,	NULL
CD45	NULL
,	NULL
and	NULL
CD5	NULL
expression	NULL
was	NULL
accomplished	NULL
by	NULL
using	NULL
the	NULL
following	NULL
reagent	NULL
combinations	NULL
.	NULL

F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fragments	NULL
of	NULL
fluorescein	NULL
isothiocyanate-conju-gated	NULL
goat	NULL
anti-mouse	NULL
p	NULL
antibody	NULL
(	NULL
Jackson	NULL
Immunoresearch	NULL
Labs	NULL
,	NULL
Inc.	NULL
,	NULL
West	NULL
Grove	NULL
,	NULL
Pa.	NULL
)	NULL
were	NULL
used	NULL
to	NULL
stain	NULL
for	NULL
relative	NULL
IgM	NULL
expression	NULL
.	NULL

Phycoerythrin-conjugated	NULL
rat	NULL
anti-8	NULL
antibody	NULL
(	NULL
Southern	NULL
Biotechnology	NULL
Associates	NULL
,	NULL
Inc.	NULL
,	NULL
Birming-ham	NULL
,	NULL
Ala.	NULL
)	NULL
was	NULL
used	NULL
for	NULL
IgD	NULL
expression	NULL
.	NULL

Biotin-conjugated	NULL
antibodies	NULL
from	NULL
the	NULL
hybridoma	NULL
M1/9.3.4	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
was	NULL
used	NULL
in	NULL
combination	NULL
with	NULL
phycoerythrin-conjugated	NULL
streptavidin	NULL
to	NULL
determine	NULL
CD45	NULL
levels	NULL
.	NULL

Finally	NULL
,	NULL
phycoerythrin-conjugated	NULL
anti-mouse	NULL
CDS	NULL
monoclonal	NULL
antibody	NULL
was	NULL
obtained	NULL
from	NULL
Pharmingen	NULL
.	NULL

Isotype	NULL
negative	NULL
controls	NULL
were	NULL
used	NULL
in	NULL
all	NULL
analyses	NULL
.	NULL

RNA	NULL
isolation	NULL
and	NULL
Northern	NULL
RNA	NULL
analysis	NULL
.	NULL

Cells	NULL
(	NULL
2.5	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
placed	NULL
in	NULL
50	NULL
ml	NULL
of	NULL
medium	NULL
and	NULL
equilibrated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37Â°C	NULL
,	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
for	NULL
1	NULL
to	NULL
2	NULL
h	NULL
prior	NULL
to	NULL
stimulation	NULL
.	NULL

Following	NULL
preincubation	NULL
,	NULL
10	NULL
ng	NULL
of	NULL
PMA	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

per	NULL
ml	NULL
or	NULL
10	NULL
ug	NULL
of	NULL
goat	NULL
anti-mouse	NULL
p.	NULL
antibody	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
was	NULL
added	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
in	NULL
the	NULL
text	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
using	NULL
the	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
method	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
RNA	NULL
were	NULL
electrophoresed	NULL
through	NULL
a	NULL
1.2	NULL
%	NULL
formaldehyde-agarose	NULL
gel	NULL
and	NULL
blotted	NULL
to	NULL
GeneScreen	NULL
Plus	NULL
nylon	NULL
membranes	NULL
(	NULL
NEN/Dupont	NULL
Co.	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

,	NULL
fixed	NULL
by	NULL
UV	NULL
irradiation	NULL
,	NULL
and	NULL
baked	NULL
for	NULL
2	NULL
h	NULL
at	NULL
80Â°C	NULL
in	NULL
a	NULL
vacuum	NULL
oven	NULL
.	NULL

The	NULL
3.1-kb	NULL
egr-1	NULL
cDNA	NULL
,	NULL
1.2-kb	NULL
GAPDH	NULL
cDNA	NULL
,	NULL
and	NULL
rlep1	NULL
(	NULL
CD44	NULL
)	NULL
were	NULL
labeled	NULL
by	NULL
incorporation	NULL
of	NULL
[	NULL
Â°Â°P	NULL
]	NULL
dCTP	NULL
by	NULL
nick	NULL
translation	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
(	NULL
Gibco	NULL
BRL	NULL
)	NULL
.	NULL

Following	NULL
a	NULL
2-	NULL
to	NULL
6-h	NULL
prehybridization	NULL
in	NULL
50	NULL
mM	NULL
PIPES	NULL
[	NULL
piperazine-N-N'-bis	NULL
(	NULL
2-ethanesulfonic	NULL
acid	NULL
)	NULL
;	NULL
pH	NULL
6.8	NULL
]	NULL
-50	NULL
mM	NULL
NaPO	NULL
,	NULL
-100	NULL
mM	NULL
NaCl-1	NULL
mM	NULL
EDTA-5	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
at	NULL
65Â°C	NULL
,	NULL
denatured	NULL
probe	NULL
was	NULL
added	NULL
and	NULL
hybridization	NULL
was	NULL
carried	NULL
out	NULL
for	NULL
12	NULL
to	NULL
16	NULL
h	NULL
at	NULL
65Â°C	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
at	NULL
65Â°C	NULL
for	NULL
20	NULL
min	NULL
each	NULL
time	NULL
with	NULL
1.0	NULL
%	NULL
SSC	NULL
(	NULL
1	NULL
%	NULL
SSC	NULL
is	NULL
0.15	NULL
M	NULL
NaCl	NULL
plus	NULL
0.015	NULL
M	NULL
sodium	NULL
citrate	NULL
)	NULL
and	NULL
5	NULL
%	NULL
SDS	NULL
;	NULL
three	NULL
times	NULL
,	NULL
for	NULL
20	NULL
min	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

each	NULL
time	NULL
,	NULL
with	NULL
0.5	NULL
%	NULL
SSC	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
;	NULL
and	NULL
three	NULL
times	NULL
,	NULL
for	NULL
20	NULL
min	NULL
each	NULL
time	NULL
,	NULL
with	NULL
0.2	NULL
%	NULL
SSC	NULL
and	NULL
0.1	NULL
%	NULL
SDS	NULL
.	NULL

Quantitative	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
using	NULL
a	NULL
PhosphorImager	NULL
and	NULL
ImageQuant	NULL
software	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Exponentially	NULL
growing	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
for	NULL
2	NULL
h	NULL
and	NULL
washed	NULL
twice	NULL
in	NULL
phos-phate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
at	NULL
4Â°C	NULL
,	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
10	NULL
,	NULL
64	NULL
)	NULL
.	NULL

Probes	NULL
were	NULL
labeled	NULL
with	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufacturer	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Bev-erly	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

and	NULL
purified	NULL
on	NULL
a	NULL
12	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
20-pl	NULL
volume	NULL
containing	NULL
10,000	NULL
dpm	NULL
of	NULL
labeled	NULL
probe	NULL
,	NULL
nuclear	NULL
extract	NULL
containing	NULL
10	NULL
pg	NULL
of	NULL
protein	NULL
,	NULL
1	NULL
g	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
-	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
N.J.	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
40	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
2-mercaptocthanol	NULL
,	NULL
and	NULL
4	NULL
%	NULL
glycerol	NULL
with	NULL
or	NULL
without	NULL
competing	NULL
oligonucleotides	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
text	NULL
.	NULL

For	NULL
antibody	NULL
blocking	NULL
experiments	NULL
,	NULL
antisera	NULL
specific	NULL
for	NULL
EGR1	NULL
or	NULL
CDK4	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
or	NULL
protein	NULL
A-adsorbed	NULL
rabbit	NULL
anti-EGR1	NULL
antibody	NULL
(	NULL
amino	NULL
acids	NULL
519	NULL
to	NULL
533	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
nuclear	NULL
extract	NULL
and	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
-	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Following	NULL
the	NULL
addition	NULL
of	NULL
reaction	NULL
buffer	NULL
and	NULL
labeled	NULL
probe	NULL
,	NULL
the	NULL
reaction	NULL
was	NULL
allowed	NULL
to	NULL
proceed	NULL
for	NULL
an	NULL
additional	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Reaction	NULL
mixtures	NULL
were	NULL
loaded	NULL
onto	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.5	NULL
%	NULL
TBE	NULL
(	NULL
1	NULL
%	NULL
TBE	NULL
is	NULL
100	NULL
mM	NULL
Tris	NULL
base-89	NULL
mM	NULL
boric	NULL
acid-2	NULL
mM	NULL
EDTA	NULL
)	NULL
and	NULL
electrophoresed	NULL
at	NULL
150	NULL
V	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
EBS-containing	NULL
probe	NULL
used	NULL
for	NULL
Fig	NULL
.	NULL

1	NULL
was	NULL
excised	NULL
from	NULL
pBLET-ERE	NULL
by	NULL
digestion	NULL
with	NULL
Psfl	NULL
and	NULL
BamHI	NULL
and	NULL
contains	NULL
the	NULL
sequence	NULL
5'-gaGGCGGGGC	NULL
Get-3	NULL
'	NULL
flanked	NULL
by	NULL
a	NULL
sequence	NULL
from	NULL
pBLET-ERE	NULL
.	NULL

Complementary	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
serum	NULL
response	NULL
element	NULL
(	NULL
SRE	NULL
)	NULL
ATTAGGACATCTGCGT-3	NULL
'	NULL
)	NULL
,	NULL
bp	NULL
-301	NULL
EGR1	NULL
(	NULL
5'-CACGGGGCGGGGGCA	NULL
GAGGG-3	NULL
'	NULL
)	NULL
,	NULL
and	NULL
mutant	NULL
bp	NULL
-301	NULL
EGR1	NULL
(	NULL
5'-CACGGGGCGGGTCTAGAG	NULL
GG-3	NULL
'	NULL
)	NULL
were	NULL
synthesized	NULL
(	NULL
Chemistry	NULL
Department	NULL
,	NULL
University	NULL
of	NULL
Pennsylvania	NULL
)	NULL
and	NULL
annealed	NULL
by	NULL
heating	NULL
to	NULL
100Â°C	NULL
for	NULL
5	NULL
min	NULL
in	NULL
100	NULL
mM	NULL
NaCl	NULL
and	NULL
slowly	NULL
cooling	NULL
to	NULL
room	NULL
temperature	NULL
.	NULL

AP1	NULL
(	NULL
5'-CGCTTGATGAGTCAGCCGGA-3	NULL
'	NULL
)	NULL
and	NULL
Spl	NULL
(	NULL
5'-ATTCGATCGGGGCGGGGCGAGC-3	NULL
'	NULL
)	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
as	NULL
well	NULL
as	NULL
EGR1	NULL
(	NULL
5	NULL
%	NULL
-GGATCCAGCGGGGGCGAGCGGGGGCGA-3	NULL
'	NULL
)	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
were	NULL
purchased	NULL
as	NULL
double-stranded	NULL
oligonucleotides	NULL
.	NULL

Nuclear	NULL
run-on	NULL
transcription	NULL
assays	NULL
.	NULL

Exponentially	NULL
growing	NULL
cells	NULL
were	NULL
ali-quoted	NULL
into	NULL
50-ml	NULL
conical	NULL
tubes	NULL
;	NULL
equilibrated	NULL
at	NULL
37Â°C	NULL
,	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
for	NULL
2	NULL
h	NULL
;	NULL
and	NULL
stimulated	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
pelleted	NULL
,	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
at	NULL
4Â°C	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
[	NULL
N-2-hydroxyethylpiperazine-NV'-2-ethanesulfonic	NULL
acid	NULL
]	NULL
[	NULL
pH	NULL
8.5	NULL
]	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1.0	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
2	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
,	NULL
1.5	NULL
ug	NULL
each	NULL
of	NULL
pepstatin	NULL
A	NULL
,	NULL
chymotrypsin	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
antipain	NULL
per	NULL
ml	NULL
)	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Following	NULL
one	NULL
wash	NULL
in	NULL
lysis	NULL
buffer	NULL
,	NULL
nuclei	NULL
were	NULL
resuspended	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
RNase	NULL
A	NULL
per	NULL
ml	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4Â°C	NULL
to	NULL
remove	NULL
cytoplasmic	NULL
RNA	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
then	NULL
washed	NULL
twice	NULL
in	NULL
lysis	NULL
buffer	NULL
at	NULL
4Â°C	NULL
and	NULL
resuspended	NULL
at	NULL
10	NULL
``	NULL
nuclei	NULL
per	NULL
100	NULL
pl	NULL
in	NULL
NSB	NULL
(	NULL
50	NULL
%	NULL
glycerol	NULL
,	NULL
0.02	NULL
M	NULL
Tris-Cl	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
0.075	NULL
M	NULL
NaCl	NULL
,	NULL
0.5	NULL
mM	NULL
EDTA	NULL
,	NULL
0.85	NULL
mM	NULL
DTT	NULL
,	NULL
0.125	NULL
mM	NULL
PMSF	NULL
)	NULL
,	NULL
placed	NULL
into	NULL
a	NULL
dry-ice-ethanol	NULL
bath	NULL
for	NULL
20	NULL
min	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-70Â°C	NULL
.	NULL

Run-on	NULL
transcription	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
26Â°C	NULL
for	NULL
10	NULL
min	NULL
in	NULL
a	NULL
200-pl	NULL
volume	NULL
with	NULL
reaction	NULL
buffer	NULL
(	NULL
29	NULL
%	NULL
glycerol	NULL
,	NULL
100	NULL
mM	NULL
Tris-Cl	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
4.0	NULL
mM	NULL
MnCl	NULL
,	NULL
,	NULL
1.2	NULL
mM	NULL
DTT	NULL
,	NULL
0.1	NULL
mM	NULL
PMSF	NULL
,	NULL
0.4	NULL
mM	NULL
EDTA	NULL
,	NULL
1.0	NULL
mM	NULL
[	NULL
each	NULL
]	NULL
nucleoside	NULL
triphosphates	NULL
,	NULL
10	NULL
mM	NULL
phosphocreatine	NULL
,	NULL
40	NULL
U	NULL
of	NULL
RNasin	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
2.5	NULL
uM	NULL
UTP	NULL
,	NULL
200	NULL
wCi	NULL
of	NULL
[	NULL
Â°Â°P	NULL
]	NULL
UTP	NULL
)	NULL
;	NULL
this	NULL
was	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1.5	NULL
U	NULL
of	NULL
RNase-free	NULL
DNase	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
Biochemicals	NULL
,	NULL
Indianapolis	NULL
,	NULL
Ind	NULL
.	NULL
)	NULL

and	NULL
incubation	NULL
at	NULL
26Â°C	NULL
for	NULL
an	NULL
additional	NULL
5	NULL
min	NULL
.	NULL

Reactions	NULL
were	NULL
terminated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
ml	NULL
of	NULL
guanidinium	NULL
thiocyanate-phenol-sodium	NULL
acetate	NULL
,	NULL
pH	NULL
4.0	NULL
,	NULL
and	NULL
RNA	NULL
was	NULL
extracted	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Unincorporated	NULL
nucleotides	NULL
were	NULL
removed	NULL
by	NULL
two	NULL
successive	NULL
ammonium	NULL
acetate	NULL
(	NULL
2.5	NULL
M	NULL
)	NULL
-ethanol	NULL
precipita-tions	NULL
.	NULL

Prehybridized	NULL
GeneScreen	NULL
Plus	NULL
membranes	NULL
containing	NULL
5	NULL
pg	NULL
of	NULL
denatured	NULL
pBluescript	NULL
SK+	NULL
with	NULL
or	NULL
without	NULL
inserts	NULL
containing	NULL
murine	NULL
CD44	NULL
(	NULL
pBlueCD44	NULL
)	NULL
,	NULL
murine	NULL
egr-1	NULL
(	NULL
pBlueEGRA3	NULL
'	NULL
)	NULL
,	NULL
or	NULL
murine	NULL
GAPDH	NULL
(	NULL
pGAPDH	NULL
)	NULL
were	NULL
hybridized	NULL
for	NULL
65	NULL
h	NULL
at	NULL
42Â°C	NULL
with	NULL
1.2	NULL
x	NULL
10	NULL
``	NULL
cpm	NULL
of	NULL
nuclear	NULL
run-on	NULL
products	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
50	NULL
%	NULL
formamide-5x	NULL
SSC-50	NULL
mM	NULL
NaPO	NULL
,	NULL
(	NULL
pH	NULL
7.0	NULL
)	NULL
-0.1	NULL
%	NULL
NaPP	NULL
;	NULL
-1	NULL
%	NULL
SDS-1	NULL
mg	NULL
of	NULL
heparin	NULL
per	NULL
ml-100	NULL
ug	NULL
of	NULL
sheared	NULL
herring	NULL
sperm	NULL
DNA	NULL
per	NULL
ml	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
washed	NULL
for	NULL
15	NULL
min	NULL
at	NULL
22Â°C	NULL
(	NULL
2	NULL
%	NULL
SSC-0.1	NULL
%	NULL
SDS	NULL
)	NULL
and	NULL
for	NULL
15	NULL
minutes	NULL
at	NULL
68Â°C	NULL
(	NULL
0.1	NULL
%	NULL
SSC-1	NULL
%	NULL
SDS	NULL
)	NULL
.	NULL

Quantitative	NULL
analysis	NULL
was	NULL
done	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Transient	NULL
transfection	NULL
and	NULL
reporter	NULL
assays	NULL
.	NULL

231.7	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
.	NULL

Exponentially	NULL
growing	NULL
231.7	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
(	NULL
CaÂ®*	NULL
and	NULL
Mg**	NULL
free	NULL
)	NULL
at	NULL
4Â°C	NULL
and	NULL
resuspended	NULL
at	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
ml	NULL
in	NULL
PBS	NULL
.	NULL

For	NULL
electroporation	NULL
,	NULL
0.6	NULL
ml	NULL
of	NULL
the	NULL
cell	NULL
suspension	NULL
was	NULL
transferred	NULL
into	NULL
precooled	NULL
0.4-cm-wide	NULL
cuvettes	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Richmond	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Following	NULL
the	NULL
addition	NULL
of	NULL
plasmid	NULL
DNA	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
,	NULL
pulsed	NULL
with	NULL
the	NULL
GenePulser	NULL
apparatus	NULL
with	NULL
capacitance	NULL
extender	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
)	NULL
at	NULL
270	NULL
V	NULL
and	NULL
960	NULL
mF	NULL
of	NULL
capacitance	NULL
,	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
a	NULL
further	NULL
10	NULL
min	NULL
,	NULL
and	NULL
transferred	NULL
into	NULL
30	NULL
ml	NULL
of	NULL
fresh	NULL
culture	NULL
medium	NULL
.	NULL

pSV	NULL
,	NULL
APAP	NULL
was	NULL
cotransfected	NULL
to	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Forty-eight	NULL
hours	NULL
following	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
CAT	NULL
and	NULL
placental	NULL
alkaline	NULL
phosphatase	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
,	NULL
55	NULL
)	NULL
.	NULL

CAT	NULL
activity	NULL
(	NULL
percent	NULL
conversion	NULL
)	NULL
was	NULL
quantitated	NULL
by	NULL
PhosphorImager	NULL
analysis	NULL
as	NULL
described	NULL
above	NULL
and	NULL
calculated	NULL
as	NULL
a	NULL
ratio	NULL
of	NULL
acetylated	NULL
chloramphenicol	NULL
to	NULL
total	NULL
chloramphenicol	NULL
(	NULL
acetylated	NULL
plus	NULL
nonacetylated	NULL
)	NULL
.	NULL

Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
EGRI-REGULATED	NULL
TRANSCRIPTION	NULL
OF	NULL
CD44	NULL
2285	NULL
A	NULL
.	NULL

300	NULL
300	NULL
300	NULL
300	NULL
C3	NULL
%	NULL
(	NULL
4	NULL
``	NULL
6	NULL
Â©	NULL
a	NULL
E	NULL
2	NULL
Z	NULL
0	NULL
@	NULL
0	NULL
5	NULL
0	NULL
0	NULL
.	NULL

10Â°	NULL
10	NULL
``	NULL
102	NULL
103	NULL
%	NULL
10	NULL
%	NULL
10	NULL
%	NULL
10	NULL
}	NULL
102	NULL
103	NULL
10+	NULL
10	NULL
%	NULL
10	NULL
!	NULL

102	NULL
103	NULL
10	NULL
%	NULL
10	NULL
%	NULL
10	NULL
!	NULL

102	NULL
103	NULL
10+	NULL
Relative	NULL
-	NULL
Fluorescence	NULL
B.	NULL
kD	NULL
1F	NULL
1	NULL
231.7	NULL
c.	NULL
111-	NULL
~	NULL
120	NULL
a	NULL
add	NULL
f	NULL
Q	NULL
.	NULL
``	NULL

2	NULL
0	NULL
|	NULL
o	NULL
231.7	NULL
&	NULL
44-	NULL
-	NULL
gig	NULL
as	NULL
g	NULL
``	NULL
=	NULL
#	NULL
sof	NULL
$	NULL
56	NULL
'	NULL
sai	NULL
*	NULL
.	NULL

aA	NULL
*	NULL
$	NULL
eol	NULL
+	NULL
]	NULL
28	NULL
~	NULL
tee	NULL
#	NULL
40	NULL
Â»	NULL
ant	NULL
#	NULL
sul	NULL
-	NULL
--	NULL
dt	NULL
~	NULL
am	NULL
ttn	NULL
am	NULL
E	NULL
``	NULL
&	NULL
g	NULL
0	NULL
Z	NULL
20p	NULL
u	NULL
Tome	NULL
ege	NULL
=	NULL
18-	NULL
~	NULL
[	NULL
antioy	NULL
0	NULL
2	NULL
1	NULL
5	NULL
0	NULL
9	NULL
1	NULL
5	NULL
0	NULL
L	NULL
1	NULL
1	NULL
i	NULL
1	NULL
i	NULL
L	NULL
1	NULL
L	NULL
i	NULL
1	NULL
stimulation	NULL
in	NULL
0	NULL
20	NULL
40	NULL
60	NULL
so	NULL
100	NULL
(	NULL
min	NULL
.	NULL
)	NULL

anti-uy	NULL
(	NULL
g/m	NULL
!	NULL
)	NULL

FIG	NULL
.	NULL

1	NULL
.	NULL

Functional	NULL
characterization	NULL
of	NULL
the	NULL
1F1	NULL
and	NULL
231.7	NULL
subclones	NULL
.	NULL

(	NULL
A	NULL
)	NULL
FACS	NULL
analysis	NULL
for	NULL
relative	NULL
IgM	NULL
,	NULL
IgD	NULL
,	NULL
CD45	NULL
,	NULL
and	NULL
CD5	NULL
surface	NULL
expression	NULL
.	NULL

IgM	NULL
levels	NULL
were	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Isotype-matched	NULL
negative	NULL
controls	NULL
were	NULL
performed	NULL
for	NULL
each	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
used	NULL
to	NULL
normalize	NULL
the	NULL
relative	NULL
level	NULL
of	NULL
each	NULL
marker	NULL
.	NULL

Shaded	NULL
curve	NULL
,	NULL
231.7	NULL
cells	NULL
;	NULL
unshaded	NULL
curve	NULL
,	NULL
1F1	NULL
cells	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Phosphotyrosine	NULL
immunoblotting	NULL
of	NULL
1F1	NULL
and	NULL
231.7	NULL
subclones	NULL
following	NULL
stimulation	NULL
with	NULL
50	NULL
pg	NULL
of	NULL
anti-p	NULL
antibody	NULL
per	NULL
ml	NULL
.	NULL

Whole-cell	NULL
lysates	NULL
after	NULL
the	NULL
indicated	NULL
period	NULL
of	NULL
stimulation	NULL
were	NULL
prepared	NULL
by	NULL
detergent	NULL
lysis	NULL
with	NULL
0.5	NULL
%	NULL
Triton	NULL
X-100	NULL
with	NULL
proteases	NULL
and	NULL
tyrosine	NULL
phosphatase	NULL
inhibitors	NULL
.	NULL

Cellular	NULL
proteins	NULL
were	NULL
separated	NULL
on	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
and	NULL
tyrosine	NULL
phosphoproteins	NULL
were	NULL
detected	NULL
by	NULL
4G10	NULL
immunoblotting	NULL
and	NULL
enhanced	NULL
chemiluminescence	NULL
by	NULL
using	NULL
a	NULL
horseradish	NULL
peroxidase-coupled	NULL
goat	NULL
anti-mouse	NULL
secondary	NULL
antibody	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Growth	NULL
response	NULL
of	NULL
1F1	NULL
and	NULL
231.7	NULL
cells	NULL
after	NULL
anti-p	NULL
antibody	NULL
stimulation	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
indicated	NULL
dose	NULL
of	NULL
anti-p	NULL
antibody	NULL
for	NULL
24	NULL
h	NULL
,	NULL
at	NULL
which	NULL
time	NULL
the	NULL
cultures	NULL
were	NULL
pulsed	NULL
with	NULL
1	NULL
Ci	NULL
of	NULL
[	NULL
*H	NULL
]	NULL
thymidine	NULL
per	NULL
well	NULL
and	NULL
harvested	NULL
16	NULL
h	NULL
later	NULL
.	NULL

Results	NULL
depict	NULL
levels	NULL
of	NULL
incorporation	NULL
of	NULL
triplicate	NULL
cultures	NULL
normalized	NULL
to	NULL
levels	NULL
of	NULL
incorporation	NULL
by	NULL
wells	NULL
containing	NULL
no	NULL
antibody	NULL
(	NULL
100	NULL
)	NULL
.	NULL

Primary	NULL
lymphocytes	NULL
were	NULL
transfected	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
5	NULL
X	NULL
10	NULL
``	NULL
LPS	NULL
blasts	NULL
were	NULL
washed	NULL
once	NULL
in	NULL
STBS	NULL
and	NULL
resuspended	NULL
at	NULL
1	NULL
%	NULL
10	NULL
``	NULL
cells	NULL
per	NULL
ml	NULL
in	NULL
STBS	NULL
containing	NULL
500	NULL
ug	NULL
of	NULL
DEAE-dextran	NULL
(	NULL
Pharmacia	NULL
)	NULL
per	NULL
ml	NULL
and	NULL
the	NULL
indicated	NULL
plasmid	NULL
DNA	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37Â°C	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
once	NULL
in	NULL
STBS	NULL
,	NULL
resuspended	NULL
at	NULL
5	NULL
X	NULL
10Â°	NULL
cells	NULL
per	NULL
ml	NULL
in	NULL
fresh	NULL
B-cell	NULL
assay	NULL
medium	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37Â°C	NULL
,	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
split	NULL
into	NULL
two	NULL
equal	NULL
groups	NULL
and	NULL
cither	NULL
were	NULL
left	NULL
unstimulated	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
.	NULL

Following	NULL
an	NULL
additional	NULL
24	NULL
h	NULL
of	NULL
incubation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

RESULTS	NULL
Subclones	NULL
of	NULL
the	NULL
WEHI-231	NULL
B-cell	NULL
lymphoma	NULL
line	NULL
differ	NULL
in	NULL
their	NULL
expression	NULL
of	NULL
EGR1	NULL
.	NULL

We	NULL
have	NULL
developed	NULL
a	NULL
system	NULL
which	NULL
can	NULL
be	NULL
used	NULL
to	NULL
examine	NULL
the	NULL
involvement	NULL
of	NULL
EGR1	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
other	NULL
genes	NULL
.	NULL

The	NULL
system	NULL
relies	NULL
on	NULL
two	NULL
subclones	NULL
of	NULL
the	NULL
WEHI-231	NULL
B-cell	NULL
lymphoma	NULL
which	NULL
differ	NULL
in	NULL
expression	NULL
of	NULL
EGR1	NULL
.	NULL

Previous	NULL
studies	NULL
in	NULL
our	NULL
laboratory	NULL
identified	NULL
a	NULL
subclone	NULL
of	NULL
WEHI-231	NULL
that	NULL
was	NULL
unable	NULL
to	NULL
express	NULL
the	NULL
egr-1	NULL
gene	NULL
in	NULL
response	NULL
to	NULL
BCR	NULL
cross-linking	NULL
or	NULL
exposure	NULL
to	NULL
the	NULL
phorbol	NULL
ester	NULL
PMA	NULL
(	NULL
56	NULL
)	NULL
.	NULL

Silencing	NULL
of	NULL
egr-1	NULL
gene	NULL
transcription	NULL
in	NULL
this	NULL
line	NULL
,	NULL
231.7	NULL
,	NULL
is	NULL
due	NULL
to	NULL
methylation	NULL
of	NULL
the	NULL
egr-1	NULL
locus	NULL
(	NULL
56	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
we	NULL
have	NULL
derived	NULL
another	NULL
subclone	NULL
,	NULL
1F1	NULL
,	NULL
in	NULL
which	NULL
induction	NULL
of	NULL
egr-1	NULL
is	NULL
observed	NULL
following	NULL
BCR	NULL
cross-linking	NULL
with	NULL
anti-p	NULL
antibodies	NULL
.	NULL

The	NULL
usefulness	NULL
of	NULL
this	NULL
system	NULL
for	NULL
analysis	NULL
of	NULL
EGR1	NULL
target	NULL
genes	NULL
depends	NULL
upon	NULL
how	NULL
similar	NULL
these	NULL
subclones	NULL
are	NULL
with	NULL
respect	NULL
to	NULL
parameters	NULL
other	NULL
than	NULL
egr-1	NULL
inducibility	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
231.7	NULL
and	NULL
1F1	NULL
are	NULL
very	NULL
similar	NULL
with	NULL
respect	NULL
to	NULL
their	NULL
expression	NULL
of	NULL
surface	NULL
IgM	NULL
,	NULL
IgD	NULL
,	NULL
CD45	NULL
,	NULL
and	NULL
CDS	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Although	NULL
there	NULL
are	NULL
slight	NULL
variations	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
surface	NULL
proteins	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
they	NULL
are	NULL
sufficient	NULL
to	NULL
affect	NULL
differences	NULL
in	NULL
the	NULL
response	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
antigen	NULL
receptor	NULL
(	NULL
IgM	NULL
in	NULL
these	NULL
stud-ies	NULL
)	NULL
stimulation	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
anti-p	NULL
antibody-induced	NULL
tyrosine	NULL
kinase	NULL
activities	NULL
and	NULL
the	NULL
growth	NULL
responses	NULL
of	NULL
these	NULL
two	NULL
subclones	NULL
of	NULL
WEHI-231	NULL
to	NULL
BCR	NULL
cross-linking	NULL
are	NULL
nearly	NULL
identical	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
and	NULL
C	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

WEHI-231	NULL
undergoes	NULL
cell	NULL
cycle	NULL
arrest	NULL
(	NULL
53	NULL
)	NULL
and	NULL
apoptosis	NULL
(	NULL
3	NULL
,	NULL
21	NULL
)	NULL
in	NULL
response	NULL
to	NULL
anti-p	NULL
antibody	NULL
stimulation	NULL
.	NULL

Both	NULL
the	NULL
1F1	NULL
and	NULL
231.7	NULL
subclones	NULL
showed	NULL
equivalent	NULL
inhibition	NULL
of	NULL
proliferation	NULL
by	NULL
anti-p	NULL
antibody	NULL
stimulation	NULL
.	NULL

While	NULL
1F1	NULL
and	NULL
231.7	NULL
cells	NULL
differ	NULL
in	NULL
their	NULL
inducible	NULL
expression	NULL
of	NULL
egr-1	NULL
in	NULL
response	NULL
to	NULL
anti-p	NULL
antibody	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
,	NULL
they	NULL
do	NULL
not	NULL
differ	NULL
in	NULL
their	NULL
inducible	NULL
expression	NULL
of	NULL
other	NULL
immediate-early	NULL
genes	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
and	NULL
C	NULL
,	NULL
both	NULL
1F1	NULL
and	NULL
231.7	NULL
cells	NULL
show	NULL
induction	NULL
of	NULL
egr-2	NULL
,	NULL
jun	NULL
B	NULL
,	NULL
and	NULL
c-myc	NULL
in	NULL
response	NULL
to	NULL
anti-p	NULL
antibody	NULL
stimulation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
c-fos	NULL
induction	NULL
was	NULL
observed	NULL
in	NULL
both	NULL
cells	NULL
following	NULL
anti-u	NULL
antibody	NULL
stimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Of	NULL
particular	NULL
interest	NULL
is	NULL
the	NULL
egr-2	NULL
response	NULL
,	NULL
2286	NULL
MALTZMAN	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
.	NULL

231.7	NULL
1F	NULL
1	NULL
w.	NULL
Â»	NULL
Â«	NULL
<	NULL
egr-	NULL
1	NULL
#	NULL
tnt	NULL
tut	NULL
tnd	NULL
tanh	NULL
tth	NULL
|	NULL
<	NULL
caro	NULL
:	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
0	NULL
2	NULL
4	NULL
0	NULL
20	NULL
4	NULL
B	NULL
.	NULL

231.7	NULL
1F	NULL
1	NULL
[	NULL
CCCP	NULL
CCCI	NULL
<	NULL
egr-	NULL
2	NULL
bp	NULL
as	NULL
tub	NULL
~*~	NULL
9	NULL
U	NULL
f-uue	NULL
f-r1ue	NULL
Time	NULL
0	NULL
1	NULL
20	NULL
4	NULL
0	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

C.	NULL
231.7	NULL
161	NULL
â	NULL
U	NULL
u..	NULL
â	NULL
.	NULL

(	NULL
âjunB	NULL
<	NULL
+	NULL
<	NULL
myc	NULL
o	NULL
oi	NULL
6	NULL
Hwa	NULL
|	NULL
<	NULL
~	NULL
1	NULL
20	NULL
4	NULL
(	NULL
min	NULL
)	NULL
FIG	NULL
.	NULL

2.	NULL
mRNA	NULL
levels	NULL
of	NULL
egr-1	NULL
,	NULL
egr-2	NULL
,	NULL
junB	NULL
,	NULL
and	NULL
c-myc	NULL
in	NULL
1F1	NULL
and	NULL
231.7	NULL
cells	NULL
after	NULL
anti-p.	NULL
antibody	NULL
stimulation	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
for	NULL
the	NULL
indicated	NULL
period	NULL
of	NULL
time	NULL
with	NULL
50	NULL
pg	NULL
of	NULL
anti-p	NULL
antibodies	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
.	NULL

Northern	NULL
blots	NULL
were	NULL
hybridized	NULL
with	NULL
labeled	NULL
probes	NULL
from	NULL
murine	NULL
cDNAs	NULL
of	NULL
egr-1	NULL
(	NULL
A	NULL
)	NULL
,	NULL
egr-2	NULL
(	NULL
1	NULL
h	NULL
)	NULL
(	NULL
B	NULL
)	NULL
,	NULL
JunB	NULL
(	NULL
C	NULL
)	NULL
,	NULL
c-myc	NULL
(	NULL
C	NULL
)	NULL
or	NULL
GAPDH	NULL
as	NULL
a	NULL
control	NULL
for	NULL
RNA	NULL
loading	NULL
.	NULL

,	NULL
unstimulated	NULL
controls	NULL
.	NULL

which	NULL
indicates	NULL
that	NULL
the	NULL
differential	NULL
inducibility	NULL
of	NULL
egr-1	NULL
in	NULL
1F1	NULL
and	NULL
231.7	NULL
cells	NULL
does	NULL
not	NULL
extend	NULL
universally	NULL
to	NULL
other	NULL
members	NULL
of	NULL
this	NULL
family	NULL
.	NULL

Thus	NULL
,	NULL
while	NULL
we	NULL
can	NULL
not	NULL
formally	NULL
rule	NULL
out	NULL
that	NULL
the	NULL
1F1	NULL
and	NULL
231.7	NULL
subclones	NULL
of	NULL
WEHI-231	NULL
differ	NULL
in	NULL
aspects	NULL
other	NULL
than	NULL
egr-1	NULL
inducibility	NULL
,	NULL
they	NULL
nonetheless	NULL
appear	NULL
to	NULL
be	NULL
very	NULL
sim-ilar	NULL
.	NULL

For	NULL
this	NULL
reason	NULL
,	NULL
we	NULL
considered	NULL
that	NULL
this	NULL
would	NULL
be	NULL
a	NULL
useful	NULL
system	NULL
to	NULL
identify	NULL
and	NULL
evaluate	NULL
EGR1	NULL
target	NULL
genes	NULL
in	NULL
stimulated	NULL
B	NULL
lymphocytes	NULL
.	NULL

Differential	NULL
inducibility	NULL
of	NULL
egr-1	NULL
in	NULL
1F1	NULL
and	NULL
231.7	NULL
B	NULL
cells	NULL
was	NULL
extended	NULL
to	NULL
include	NULL
stimulation	NULL
with	NULL
the	NULL
phorbol	NULL
ester	NULL
analog	NULL
PMA	NULL
.	NULL

As	NULL
with	NULL
anti-p	NULL
antibody	NULL
stimulation	NULL
,	NULL
Northern	NULL
analysis	NULL
of	NULL
egr-1	NULL
revealed	NULL
a	NULL
lack	NULL
of	NULL
inducible	NULL
message	NULL
in	NULL
the	NULL
231.7	NULL
subclone	NULL
,	NULL
whereas	NULL
PMA	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
of	NULL
1F1	NULL
cells	NULL
led	NULL
to	NULL
a	NULL
rapid	NULL
(	NULL
within	NULL
30	NULL
min	NULL
)	NULL
and	NULL
transient	NULL
induction	NULL
of	NULL
egr-1	NULL
mRNA	NULL
.	NULL

By	NULL
bypassing	NULL
the	NULL
antigen	NULL
receptor	NULL
and	NULL
directly	NULL
initiating	NULL
BCR-associated	NULL
signaling	NULL
pathways	NULL
leading	NULL
to	NULL
egr-1	NULL
gene	NULL
induction	NULL
(	NULL
36	NULL
)	NULL
,	NULL
PMA	NULL
is	NULL
believed	NULL
to	NULL
model	NULL
Ig	NULL
M-induced	NULL
egr-1	NULL
.	NULL

In	NULL
so	NULL
doing	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
PMA	NULL
to	NULL
be	NULL
a	NULL
more	NULL
efficient	NULL
inducer	NULL
of	NULL
egr-1	NULL
expression	NULL
than	NULL
anti-p	NULL
antibody	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
kinetics	NULL
of	NULL
PMA-induced	NULL
egr-1	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
closely	NULL
parallel	NULL
the	NULL
induction	NULL
of	NULL
egr-1	NULL
in	NULL
primary	NULL
B	NULL
lymphocytes	NULL
by	NULL
PMA	NULL
or	NULL
anti-p	NULL
antibody	NULL
(	NULL
55	NULL
)	NULL
.	NULL

As	NULL
would	NULL
be	NULL
expected	NULL
from	NULL
Northern	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
stimulated	NULL
1F1	NULL
cells	NULL
expressed	NULL
the	NULL
EGR1	NULL
protein	NULL
,	NULL
whereas	NULL
231.7	NULL
cells	NULL
do	NULL
not	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
PMA-stimulated	NULL
1F1	NULL
cells	NULL
but	NULL
not	NULL
231.7	NULL
cells	NULL
exhibited	NULL
EGR1	NULL
binding	NULL
to	NULL
a	NULL
probe	NULL
containing	NULL
a	NULL
consensus	NULL
EGR1	NULL
binding	NULL
site	NULL
that	NULL
was	NULL
specifically	NULL
inhibited	NULL
by	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
two	NULL
consensus	NULL
binding	NULL
sites	NULL
(	NULL
EGR1	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
an	NULL
irrelevant	NULL
binding	NULL
site	NULL
,	NULL
the	NULL
c-fos	NULL
SRE	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
this	NULL
protein-DNA	NULL
complex	NULL
.	NULL

Only	NULL
a	NULL
single	NULL
complex	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
unlabeled	NULL
EGR1	NULL
site-containing	NULL
oligonucleotide	NULL
,	NULL
suggesting	NULL
either	NULL
that	NULL
only	NULL
one	NULL
EGR	NULL
family	NULL
member	NULL
was	NULL
present	NULL
in	NULL
these	NULL
extracts	NULL
or	NULL
that	NULL
if	NULL
multiple	NULL
proteins	NULL
bind	NULL
specifically	NULL
,	NULL
they	NULL
exhibit	NULL
identical	NULL
mobilities	NULL
under	NULL
the	NULL
gel	NULL
conditions	NULL
used	NULL
in	NULL
this	NULL
experiment	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
this	NULL
complex	NULL
was	NULL
due	NULL
solely	NULL
to	NULL
EGR1	NULL
binding	NULL
,	NULL
we	NULL
performed	NULL
binding	NULL
reactions	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
antiserum	NULL
raised	NULL
against	NULL
a	NULL
C-terminal	NULL
peptide	NULL
of	NULL
EGR1	NULL
that	NULL
is	NULL
unique	NULL
to	NULL
EGR1	NULL
among	NULL
members	NULL
of	NULL
this	NULL
family	NULL
(	NULL
15	NULL
,	NULL
26	NULL
,	NULL
47	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Prein-cubation	NULL
with	NULL
anti-EGR1	NULL
antiserum	NULL
inhibited	NULL
EGR1	NULL
site-spe-cific	NULL
binding	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

This	NULL
result	NULL
,	NULL
taken	NULL
together	NULL
with	NULL
the	NULL
oligonucleotide	NULL
competition	NULL
data	NULL
,	NULL
indicated	NULL
that	NULL
extracts	NULL
prepared	NULL
from	NULL
PMA-stimulated	NULL
1F1	NULL
cells	NULL
do	NULL
not	NULL
contain	NULL
detectable	NULL
EGR2	NULL
,	NULL
EGR3	NULL
,	NULL
EGR4	NULL
,	NULL
or	NULL
WTI	NULL
binding	NULL
activities	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
they	NULL
express	NULL
egr-2	NULL
mRNA	NULL
at	NULL
detect-able	NULL
,	NULL
albeit	NULL
low	NULL
,	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
protein	NULL
levels	NULL
are	NULL
insufficient	NULL
to	NULL
form	NULL
detectable	NULL
complexes	NULL
,	NULL
indicating	NULL
that	NULL
EGR1	NULL
is	NULL
the	NULL
predominant	NULL
DNA-binding	NULL
protein	NULL
from	NULL
this	NULL
family	NULL
that	NULL
is	NULL
expressed	NULL
in	NULL
this	NULL
system	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
while	NULL
1F1	NULL
cells	NULL
expressed	NULL
both	NULL
egr-1	NULL
message	NULL
and	NULL
protein	NULL
following	NULL
PMA	NULL
and	NULL
anti-u	NULL
antibody	NULL
stimulation	NULL
,	NULL
231.7	NULL
cells	NULL
do	NULL
not	NULL
manifest	NULL
detectable	NULL
expression	NULL
following	NULL
stimulation	NULL
by	NULL
these	NULL
agents	NULL
.	NULL

Increased	NULL
CD44	NULL
mRNA	NULL
expression	NULL
by	NULL
PMA	NULL
or	NULL
BCR	NULL
stimulation	NULL
correlates	NULL
with	NULL
EGR1	NULL
inducibility	NULL
and	NULL
is	NULL
regulated	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
possibility	NULL
that	NULL
EGR1	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
inducible	NULL
transcription	NULL
of	NULL
CD44	NULL
,	NULL
we	NULL
compared	NULL
CD44	NULL
mRNA	NULL
levels	NULL
in	NULL
231.7	NULL
and	NULL
1F1	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
BCR	NULL
signaling	NULL
.	NULL

Three	NULL
distinct	NULL
CD44	NULL
transcripts	NULL
(	NULL
cor-responding	NULL
to	NULL
published	NULL
lengths	NULL
of	NULL
1.3	NULL
,	NULL
2.7	NULL
,	NULL
and	NULL
3.9	NULL
kb	NULL
[	NULL
5	NULL
]	NULL
)	NULL
were	NULL
constitutively	NULL
expressed	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
multiple	NULL
transcripts	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
the	NULL
result	NULL
of	NULL
alternative	NULL
splicing	NULL
(	NULL
54	NULL
)	NULL
and	NULL
differential	NULL
polyadenyla-tion	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Stimulation	NULL
through	NULL
the	NULL
BCR	NULL
with	NULL
anti-p	NULL
antibodies	NULL
stimulated	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
all	NULL
three	NULL
CD44	NULL
mRNAs	NULL
in	NULL
1F1	NULL
cells	NULL
.	NULL

An	NULL
increase	NULL
was	NULL
also	NULL
detectable	NULL
in	NULL
the	NULL
231.7	NULL
line	NULL
,	NULL
but	NULL
the	NULL
magnitude	NULL
of	NULL
this	NULL
increase	NULL
was	NULL
much	NULL
less	NULL
than	NULL
that	NULL
observed	NULL
with	NULL
1F1	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
inducible	NULL
expression	NULL
peaked	NULL
at	NULL
4	NULL
h.	NULL
To	NULL
control	NULL
for	NULL
general	NULL
increases	NULL
in	NULL
transcription	NULL
and	NULL
RNA	NULL
loading	NULL
,	NULL
message	NULL
levels	NULL
of	NULL
the	NULL
housekeeping	NULL
gene	NULL
GAPDH	NULL
were	NULL
measured	NULL
.	NULL

GAPDH	NULL
mRNA	NULL
levels	NULL
did	NULL
not	NULL
vary	NULL
significantly	NULL
between	NULL
1F1	NULL
and	NULL
231.7	NULL
cells	NULL
nor	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
A	NULL
.	NULL

231.7	NULL
1F1	NULL
1	NULL
1	NULL
PMA	NULL
(	NULL
hrs	NULL
.	NULL
)	NULL

o	NULL
0.5	NULL
1	NULL
20	NULL
4	NULL
s	NULL
24Â°	NULL
'	NULL
o	NULL
os	NULL
2	NULL
4	NULL
8	NULL
24Â°	NULL
285-	NULL
Â»	NULL
w*	NULL
G	NULL
>	NULL
me	NULL
-	NULL
egr-1	NULL
185-Â®	NULL
Bbeo	NULL
s-	NULL
s0800	NULL
-	NULL
0	NULL
@	NULL
0e	NULL
08	NULL
e	NULL
o	NULL
O-	NULL
cason	NULL
B	NULL
.	NULL

231.7	NULL
1m	NULL
It-	NULL
<	NULL
W	NULL
<	NULL
3	NULL
-	NULL
Eo	NULL
u	NULL
Â§	NULL
&	NULL
ow	NULL
Â§	NULL
a	NULL
5	NULL
-	NULL
8	NULL
5	NULL
u	NULL
;	NULL
bas	NULL
S	NULL
g	NULL
â	NULL
Ã©	NULL
compemor	NULL
F	NULL
I~*~~al	NULL
fall	NULL
[	NULL
rar	NULL
--	NULL
3	NULL
z	NULL
p	NULL
2	NULL
g	NULL
G	NULL
a	NULL
2	NULL
?	NULL

8	NULL
G	NULL
â¬	NULL
8	NULL
Â§	NULL
$	NULL
f	NULL
Â§	NULL
Â§	NULL
Â§	NULL
?	NULL

:	NULL
gos	NULL
.	NULL

=EGR1	NULL
FIG	NULL
.	NULL

3.	NULL
egr-1	NULL
message	NULL
and	NULL
protein	NULL
expression	NULL
are	NULL
induced	NULL
by	NULL
PMA	NULL
in	NULL
1F1	NULL
but	NULL
not	NULL
in	NULL
231.7	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Time	NULL
course	NULL
of	NULL
egr-1	NULL
RNA	NULL
induction	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
total	NULL
cellular	NULL
RNA	NULL
isolated	NULL
from	NULL
231.7	NULL
and	NULL
1F1	NULL
cells	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
following	NULL
exposure	NULL
to	NULL
PMA	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

was	NULL
subjected	NULL
to	NULL
Northern	NULL
blot	NULL
analysis	NULL
for	NULL
egr-1	NULL
and	NULL
GAPDH	NULL
.	NULL

The	NULL
locations	NULL
of	NULL
28	NULL
$	NULL
and	NULL
188	NULL
rRNA	NULL
bands	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Gel	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
8	NULL
mg	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
231.7	NULL
and	NULL
1F1	NULL
cells	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
.	NULL

The	NULL
65-bp	NULL
*Â°P-labeled	NULL
probe	NULL
used	NULL
contains	NULL
a	NULL
single	NULL
EGR1	NULL
consensus	NULL
binding	NULL
site	NULL
and	NULL
flanking	NULL
plasmid	NULL
DNA	NULL
.	NULL

Unlabeled	NULL
oligonucleotide	NULL
or	NULL
anti-EGR1	NULL
antiserum	NULL
was	NULL
preincubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
at	NULL
4Â°C	NULL
for	NULL
15	NULL
min	NULL
,	NULL
the	NULL
probe	NULL
was	NULL
added	NULL
,	NULL
binding	NULL
was	NULL
allowed	NULL
to	NULL
proceed	NULL
for	NULL
an	NULL
additional	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
the	NULL
reactions	NULL
were	NULL
separated	NULL
through	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide-0.5	NULL
%	NULL
TBE	NULL
gel	NULL
.	NULL

following	NULL
stimulation	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

Similar	NULL
differential	NULL
induction	NULL
of	NULL
CD44	NULL
was	NULL
also	NULL
seen	NULL
when	NULL
PMA	NULL
was	NULL
used	NULL
as	NULL
a	NULL
stimulus	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
induction	NULL
of	NULL
CD44	NULL
message	NULL
following	NULL
either	NULL
PMA	NULL
or	NULL
anti-p	NULL
antibody	NULL
stimulation	NULL
correlates	NULL
with	NULL
the	NULL
capacity	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
express	NULL
EGR1	NULL
.	NULL

The	NULL
differential	NULL
levels	NULL
of	NULL
CD44	NULL
RNA	NULL
detected	NULL
by	NULL
Northern	NULL
analysis	NULL
could	NULL
be	NULL
due	NULL
either	NULL
to	NULL
increased	NULL
rates	NULL
of	NULL
transcription	NULL
or	NULL
to	NULL
differences	NULL
in	NULL
CD44	NULL
RNA	NULL
stability	NULL
or	NULL
to	NULL
both	NULL
.	NULL

A	NULL
direct	NULL
role	NULL
for	NULL
the	NULL
EGR1	NULL
transcription	NULL
factor	NULL
implies	NULL
effects	NULL
at	NULL
the	NULL
level	NULL
of	NULL
CD44	NULL
transcription	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
importance	NULL
of	NULL
induced	NULL
transcription	NULL
of	NULL
the	NULL
CD44	NULL
gene	NULL
to	NULL
the	NULL
increase	NULL
in	NULL
mRNA	NULL
levels	NULL
,	NULL
measurements	NULL
of	NULL
de	NULL
novo	NULL
transcription	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
nuclear	NULL
run-on	NULL
assays	NULL
.	NULL

Transcription	NULL
of	NULL
CD44	NULL
in	NULL
1F1	NULL
cells	NULL
was	NULL
induced	NULL
within	NULL
1	NULL
h	NULL
of	NULL
PMA	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
kinetics	NULL
of	NULL
steady-state	NULL
RNA	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
the	NULL
rate	NULL
of	NULL
CD44	NULL
transcription	NULL
peaked	NULL
between	NULL
1	NULL
and	NULL
3	NULL
h	NULL
following	NULL
stimulation	NULL
.	NULL

To	NULL
compare	NULL
levels	NULL
of	NULL
transcription	NULL
at	NULL
different	NULL
times	NULL
between	NULL
the	NULL
two	NULL
cell	NULL
lines	NULL
,	NULL
we	NULL
quantitated	NULL
the	NULL
band	NULL
intensities	NULL
and	NULL
normalized	NULL
these	NULL
values	NULL
to	NULL
the	NULL
transcription	NULL
of	NULL
GAPDH	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Stimulation	NULL
indices	NULL
indicated	NULL
that	NULL
CD44	NULL
transcription	NULL
was	NULL
induced	NULL
approximately	NULL
5-fold	NULL
within	NULL
2	NULL
h	NULL
in	NULL
1F1	NULL
cells	NULL
,	NULL
while	NULL
less	NULL
than	NULL
1.3-fold	NULL
induction	NULL
was	NULL
seen	NULL
at	NULL
any	NULL
time	NULL
with	NULL
231.7	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

While	NULL
not	NULL
ruling	NULL
out	NULL
the	NULL
in	NULL
EGRI-REGULATED	NULL
TRANSCRIPTION	NULL
OF	NULL
CD44	NULL
2287	NULL
A	NULL
.	NULL

231.7	NULL
1F1	NULL
anti	NULL
<	NULL
u	NULL
-	NULL
O0	NULL
2	NULL
4	NULL
8	NULL
0	NULL
2	NULL
4	NULL
8	NULL
pil	NULL
W	NULL
Â»	NULL
--	NULL
--	NULL
Co44	NULL
R4	NULL
<	NULL
-tw	NULL
_	NULL
--	NULL
B.	NULL
en	NULL
6	NULL
0D	NULL
-	NULL
casos	NULL
:	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Comparison	NULL
of	NULL
anti-p	NULL
antibody-induced	NULL
CD44	NULL
mRNA	NULL
levels	NULL
in	NULL
231.7	NULL
and	NULL
1F1	NULL
cells	NULL
.	NULL

Total	NULL
RNA	NULL
isolated	NULL
from	NULL
231.7	NULL
and	NULL
1F1	NULL
cells	NULL
following	NULL
stimulation	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
goat	NULL
anti-p.	NULL
antibody	NULL
per	NULL
ml	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
(	NULL
in	NULL
hours	NULL
)	NULL
was	NULL
subjected	NULL
to	NULL
Northern	NULL
analysis	NULL
for	NULL
CD44	NULL
(	NULL
A	NULL
)	NULL
and	NULL
GAPDH	NULL
(	NULL
B	NULL
)	NULL
.	NULL

CD44-specific	NULL
transcripts	NULL
corresponding	NULL
to	NULL
3.9-	NULL
,	NULL
2.7-	NULL
,	NULL
and	NULL
1.3-kb	NULL
species	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

The	NULL
migration	NULL
of	NULL
28S	NULL
and	NULL
188	NULL
rRNA	NULL
bands	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
dashes	NULL
on	NULL
the	NULL
left	NULL
.	NULL

volvement	NULL
of	NULL
increased	NULL
message	NULL
stability	NULL
as	NULL
a	NULL
component	NULL
of	NULL
the	NULL
increase	NULL
in	NULL
egr-1	NULL
mRNA	NULL
levels	NULL
after	NULL
PMA	NULL
stimulation	NULL
of	NULL
1F1	NULL
B	NULL
cells	NULL
,	NULL
these	NULL
results	NULL
clearly	NULL
establish	NULL
a	NULL
stimulus-induced	NULL
increase	NULL
in	NULL
the	NULL
rate	NULL
of	NULL
egr-1	NULL
gene	NULL
transcription	NULL
.	NULL

If	NULL
EGR1	NULL
protein	NULL
regulates	NULL
the	NULL
transcription	NULL
of	NULL
CD44	NULL
,	NULL
we	NULL
A	NULL
.	NULL

Time	NULL
of	NULL
stimulation	NULL
of	NULL
1F1	NULL
(	NULL
hours	NULL
)	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
CD44	NULL
e	NULL
egr-1	NULL
me	NULL
Â®	NULL
%	NULL
GAPDH	NULL
baud	NULL
-	NULL
m	NULL
@	NULL
me	NULL
pBluescript	NULL
B	NULL
.	NULL

6	NULL
meosi.7	NULL
s	NULL
}	NULL
Gir	NULL
Index	NULL
Stimulation	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
PMA	NULL
-	NULL
Stimulation	NULL
(	NULL
hours	NULL
)	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Differential	NULL
induction	NULL
of	NULL
CD44	NULL
transcriptional	NULL
initiation	NULL
in	NULL
1F1	NULL
and	NULL
231.7	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclei	NULL
were	NULL
isolated	NULL
from	NULL
1F1	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
stimulated	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
and	NULL
were	NULL
used	NULL
as	NULL
templates	NULL
to	NULL
produce	NULL
*Â°P-labeled	NULL
nuclear	NULL
run-on	NULL
transcription	NULL
probes	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Five	NULL
micrograms	NULL
each	NULL
of	NULL
pBluescript	NULL
SK+	NULL
vectors	NULL
containing	NULL
either	NULL
CD44	NULL
,	NULL
egr-1	NULL
,	NULL
or	NULL
GAPDH	NULL
or	NULL
containing	NULL
no	NULL
insert	NULL
were	NULL
immobilized	NULL
onto	NULL
GeneScreen	NULL
Plus	NULL
membranes	NULL
.	NULL

The	NULL
run-on	NULL
transcription	NULL
products	NULL
were	NULL
hybridized	NULL
to	NULL
the	NULL
membranes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Quantitative	NULL
analysis	NULL
of	NULL
PMA-stimulated	NULL
CD44	NULL
transcription	NULL
in	NULL
231.7	NULL
and	NULL
1F1	NULL
cells	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
a	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

CD44	NULL
band	NULL
intensities	NULL
from	NULL
the	NULL
hybridized	NULL
filters	NULL
in	NULL
panel	NULL
A	NULL
and	NULL
a	NULL
simultancous	NULL
experiment	NULL
using	NULL
nuclei	NULL
from	NULL
PMA-stimulated	NULL
231.7	NULL
cells	NULL
were	NULL
quantitated	NULL
and	NULL
normalized	NULL
to	NULL
GAPDH	NULL
intensities	NULL
at	NULL
each	NULL
time	NULL
point	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
fold	NULL
induction	NULL
versus	NULL
unstimulated	NULL
levels	NULL
.	NULL

2288	NULL
MALTZMAN	NULL
ET	NULL
AL	NULL
.	NULL

extract	NULL
g	NULL
{	NULL
minutes	NULL
-	NULL
PMA	NULL
)	NULL
2	NULL
0	NULL
15	NULL
30	NULL
60	NULL
120	NULL
60	NULL
60	NULL
-m	NULL
competitor	NULL
=	NULL
-	NULL
=	NULL
=	NULL
=	NULL
=	NULL
EGR1	NULL
EGR1	NULL
>	NULL
r	NULL
*I	NULL
free	NULL
probe	NULL
-	NULL
>	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

PMA	NULL
rapidly	NULL
induces	NULL
nuclear	NULL
EGR1	NULL
protein	NULL
.	NULL

EMSA	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
5	NULL
pg	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
1F1	NULL
cells	NULL
which	NULL
had	NULL
been	NULL
stimulated	NULL
with	NULL
PMA	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
-labeled	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
two	NULL
consensus	NULL
EGR1	NULL
binding	NULL
sites	NULL
for	NULL
15	NULL
min	NULL
;	NULL
this	NULL
was	NULL
followed	NULL
by	NULL
separation	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide-0.5	NULL
%	NULL
TBE	NULL
gel	NULL
and	NULL
autoradiography	NULL
.	NULL

In	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
,	NULL
a	NULL
20-	NULL
or	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
competing	NULL
oligonucleotides	NULL
was	NULL
preincubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
60-min-stimulated	NULL
1F1	NULL
cells	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
labeled	NULL
probe	NULL
.	NULL

would	NULL
expect	NULL
that	NULL
egr-l-specific	NULL
transcription	NULL
would	NULL
precede	NULL
that	NULL
of	NULL
CD44	NULL
.	NULL

The	NULL
rate	NULL
of	NULL
egr-1	NULL
transcription	NULL
was	NULL
induced	NULL
by	NULL
greater	NULL
than	NULL
18-fold	NULL
within	NULL
1	NULL
h	NULL
following	NULL
PMA	NULL
treatment	NULL
of	NULL
1F1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Among	NULL
the	NULL
times	NULL
examined	NULL
,	NULL
maximal	NULL
levels	NULL
of	NULL
egr-1	NULL
transcription	NULL
were	NULL
attained	NULL
at	NULL
1	NULL
h	NULL
(	NULL
versus	NULL
2	NULL
h	NULL
for	NULL
CD44	NULL
)	NULL
,	NULL
decreasing	NULL
over	NULL
the	NULL
next	NULL
3	NULL
h.	NULL
As	NULL
expected	NULL
,	NULL
egr-1	NULL
transcription	NULL
in	NULL
231.7	NULL
cells	NULL
was	NULL
not	NULL
detectable	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
nuclear	NULL
EGR1	NULL
protein	NULL
correlate	NULL
with	NULL
CD44	NULL
transcription	NULL
.	NULL

Although	NULL
the	NULL
kinetics	NULL
of	NULL
egr-1	NULL
transcription	NULL
correlate	NULL
with	NULL
the	NULL
transcription	NULL
of	NULL
CD44	NULL
,	NULL
the	NULL
relevance	NULL
of	NULL
EGR1	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
of	NULL
the	NULL
CD44	NULL
gene	NULL
depends	NULL
on	NULL
the	NULL
kinetics	NULL
of	NULL
EGR1	NULL
protein	NULL
available	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

To	NULL
address	NULL
whether	NULL
EGR1	NULL
protein	NULL
is	NULL
induced	NULL
with	NULL
appropriate	NULL
kinetics	NULL
to	NULL
regulate	NULL
CD44	NULL
transcription	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
within	NULL
1	NULL
to	NULL
2	NULL
h	NULL
)	NULL
,	NULL
1F1	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
PMA	NULL
for	NULL
varying	NULL
periods	NULL
of	NULL
time	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
used	NULL
for	NULL
EMSA	NULL
with	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
two	NULL
tandem	NULL
EGR1	NULL
consensus	NULL
binding	NULL
motifs	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

No	NULL
detectable	NULL
EGR1	NULL
binding	NULL
was	NULL
seen	NULL
with	NULL
unstimulated	NULL
1F1	NULL
cells	NULL
or	NULL
with	NULL
cells	NULL
stimulated	NULL
for	NULL
15	NULL
min	NULL
.	NULL

However	NULL
,	NULL
nuclear	NULL
EGR1	NULL
protein	NULL
could	NULL
be	NULL
detected	NULL
beginning	NULL
within	NULL
30	NULL
min	NULL
following	NULL
PMA	NULL
stimulation	NULL
,	NULL
with	NULL
binding	NULL
activity	NULL
continuing	NULL
to	NULL
increase	NULL
until	NULL
2	NULL
h	NULL
following	NULL
stimulation	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
EGR1	NULL
binding	NULL
activity	NULL
,	NULL
therefore	NULL
,	NULL
closely	NULL
parallel	NULL
the	NULL
induction	NULL
of	NULL
CD44	NULL
specific	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

EGR-1	NULL
binds	NULL
with	NULL
low	NULL
affinity	NULL
to	NULL
a	NULL
site	NULL
at	NULL
bp	NULL
-301	NULL
of	NULL
the	NULL
CD44	NULL
promoter	NULL
region	NULL
.	NULL

While	NULL
EGR1	NULL
is	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
with	NULL
appropriate	NULL
kinetics	NULL
to	NULL
regulate	NULL
CD44	NULL
transcription	NULL
,	NULL
this	NULL
regulation	NULL
presumes	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
EGR1	NULL
protein	NULL
to	NULL
specifically	NULL
interact	NULL
with	NULL
the	NULL
CD44	NULL
promoter	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
CD44	NULL
promoter	NULL
indicated	NULL
two	NULL
potential	NULL
EGR1	NULL
binding	NULL
motifs	NULL
centered	NULL
at	NULL
bp	NULL
-600	NULL
and	NULL
-301	NULL
,	NULL
relative	NULL
to	NULL
the	NULL
translation	NULL
start	NULL
site	NULL
.	NULL

Since	NULL
each	NULL
of	NULL
these	NULL
elements	NULL
differs	NULL
from	NULL
the	NULL
consensus	NULL
binding	NULL
site	NULL
by	NULL
at	NULL
least	NULL
1	NULL
bp	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
in	NULL
vitro	NULL
binding	NULL
studies	NULL
to	NULL
determine	NULL
binding	NULL
of	NULL
EGR1	NULL
to	NULL
DNA	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

fragments	NULL
containing	NULL
each	NULL
of	NULL
these	NULL
elements	NULL
.	NULL

Preliminary	NULL
EMSA	NULL
experiments	NULL
using	NULL
large	NULL
(	NULL
approximately	NULL
100-bp	NULL
)	NULL
fragments	NULL
which	NULL
included	NULL
the	NULL
potential	NULL
EGR1	NULL
motifs	NULL
showed	NULL
an	NULL
EGR1-specific	NULL
band	NULL
shift	NULL
of	NULL
a	NULL
fragment	NULL
containing	NULL
the	NULL
bp	NULL
-301	NULL
motif	NULL
but	NULL
not	NULL
the	NULL
bp	NULL
-600	NULL
motif	NULL
(	NULL
34a	NULL
)	NULL
,	NULL
thereby	NULL
ruling	NULL
out	NULL
the	NULL
site	NULL
at	NULL
bp	NULL
-600	NULL
as	NULL
a	NULL
potential	NULL
mediator	NULL
of	NULL
EGR1-regulated	NULL
CD44	NULL
expression	NULL
.	NULL

Because	NULL
the	NULL
motif	NULL
located	NULL
at	NULL
bp	NULL
-301	NULL
is	NULL
a	NULL
nonconsensus	NULL
binding	NULL
motif	NULL
,	NULL
further	NULL
studies	NULL
using	NULL
a	NULL
synthetic	NULL
oligonucleotide	NULL
were	NULL
carried	NULL
out	NULL
to	NULL
confirm	NULL
EGR1	NULL
binding	NULL
and	NULL
to	NULL
compare	NULL
the	NULL
affinity	NULL
of	NULL
EGR1	NULL
for	NULL
this	NULL
sequence	NULL
to	NULL
that	NULL
of	NULL
the	NULL
consensus	NULL
.	NULL

Our	NULL
system	NULL
utilizing	NULL
the	NULL
231.7	NULL
and	NULL
1F1	NULL
cell	NULL
lines	NULL
offers	NULL
the	NULL
advantage	NULL
of	NULL
determining	NULL
EGR1	NULL
binding	NULL
by	NULL
using	NULL
murine	NULL
nuclear	NULL
extracts	NULL
rather	NULL
than	NULL
in	NULL
vitro-synthesized	NULL
or	NULL
bacterially	NULL
expressed	NULL
protein	NULL
.	NULL

If	NULL
EGR1	NULL
binds	NULL
to	NULL
the	NULL
DNA	NULL
probe	NULL
,	NULL
a	NULL
shifted	NULL
band	NULL
unique	NULL
to	NULL
nuclear	NULL
extracts	NULL
of	NULL
stimulated	NULL
1F1	NULL
cells	NULL
should	NULL
be	NULL
present	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
PMA-stimulated	NULL
231.7	NULL
and	NULL
1F1	NULL
cells	NULL
were	NULL
used	NULL
in	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
with	NULL
a	NULL
labeled	NULL
oligonucleotide	NULL
probe	NULL
spanning	NULL
bp	NULL
-288	NULL
to	NULL
-307	NULL
of	NULL
the	NULL
CD44	NULL
promoter	NULL
.	NULL

Incubation	NULL
of	NULL
the	NULL
probe	NULL
with	NULL
stimulated	NULL
extracts	NULL
from	NULL
231.7	NULL
cells	NULL
resulted	NULL
in	NULL
two	NULL
shifted	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
high-mobility	NULL
complex	NULL
was	NULL
not	NULL
inhibited	NULL
by	NULL
excess	NULL
unlabeled	NULL
probe	NULL
and	NULL
was	NULL
attributed	NULL
to	NULL
nonspecific	NULL
binding	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Competition	NULL
analysis	NULL
with	NULL
unlabeled	NULL
oligonucleotides	NULL
for	NULL
Spl	NULL
and	NULL
EGR1	NULL
indicated	NULL
that	NULL
the	NULL
low-mobility	NULL
complex	NULL
was	NULL
due	NULL
to	NULL
Spl	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
.	NULL

Use	NULL
of	NULL
stimulated	NULL
extracts	NULL
from	NULL
1F1	NULL
cells	NULL
resulted	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
an	NULL
additional	NULL
low-mobility	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
specifically	NULL
inhibited	NULL
by	NULL
EGR1	NULL
consensus	NULL
oligonucleotides	NULL
but	NULL
not	NULL
Sp1	NULL
or	NULL
AP1	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
compare	NULL
lane	NULL
7	NULL
and	NULL
lanes	NULL
6	NULL
and	NULL
8	NULL
)	NULL
in	NULL
other	NULL
experiments	NULL
and	NULL
comigrated	NULL
with	NULL
a	NULL
band	NULL
specifically	NULL
inhibited	NULL
with	NULL
an	NULL
EGR1-specific	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
only	NULL
detectable	NULL
EGR	NULL
family	NULL
protein	NULL
present	NULL
in	NULL
1F1	NULL
extracts	NULL
that	NULL
binds	NULL
to	NULL
1F1	NULL
T	NULL
t-	NULL
&	NULL
extract	NULL
-	NULL
231.7	NULL
161	NULL
&	NULL
_J	NULL
;	NULL
D	NULL
3	NULL
Â£	NULL
competitor	NULL
-	NULL
-	NULL
-	NULL
SP1	NULL
EGR1	NULL
-	NULL
SP1	NULL
EGR1	NULL
â¬	NULL
Â£	NULL
&	NULL
SP1-	NULL
>	NULL
l	NULL
#	NULL
#	NULL
EGR1	NULL
>	NULL
``	NULL
1	NULL
f*	NULL
p	NULL
.	NULL

-	NULL
Jina	NULL
to	NULL
#	NULL
Gab	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

EGR1	NULL
binds	NULL
to	NULL
a	NULL
region	NULL
at	NULL
bp	NULL
-301	NULL
within	NULL
the	NULL
human	NULL
CD44	NULL
promoter	NULL
.	NULL

Five	NULL
micrograms	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
231.7	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
)	NULL
and	NULL
1F1	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
10	NULL
)	NULL
cells	NULL
which	NULL
had	NULL
been	NULL
stimulated	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
for	NULL
2	NULL
h	NULL
was	NULL
tested	NULL
for	NULL
binding	NULL
to	NULL
a	NULL
*Â°P-labeled	NULL
oligonucleotide	NULL
probe	NULL
spanning	NULL
bp	NULL
-288	NULL
through	NULL
-307	NULL
of	NULL
the	NULL
CD44	NULL
promoter	NULL
.	NULL

Unlabeled	NULL
oligonucleotides	NULL
containing	NULL
an	NULL
Sp1	NULL
binding	NULL
site	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
,	NULL
two	NULL
EGR1	NULL
binding	NULL
sites	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
7	NULL
)	NULL
,	NULL
an	NULL
AP1	NULL
binding	NULL
site	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
and	NULL
antisera	NULL
specific	NULL
for	NULL
EGR1	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
or	NULL
CDK4	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
the	NULL
nuclear	NULL
extracts	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4Â°C	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
were	NULL
followed	NULL
immediately	NULL
by	NULL
separation	NULL
of	NULL
binding	NULL
reaction	NULL
mixtures	NULL
on	NULL
either	NULL
a	NULL
6	NULL
%	NULL
X	NULL
Tris-glycine	NULL
gel	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
7	NULL
)	NULL
or	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide-0.5	NULL
%	NULL
X	NULL
TBE	NULL
gel	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
autoradiographed	NULL
.	NULL

The	NULL
mobilities	NULL
of	NULL
EGR1-	NULL
and	NULL
SP1-specific	NULL
binding	NULL
complexes	NULL
(	NULL
based	NULL
on	NULL
competition	NULL
experiments	NULL
)	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
left	NULL
.	NULL

Â®	NULL
,	NULL
nonspecific	NULL
binding	NULL
complex	NULL
.	NULL

Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
EGRI-REGULATED	NULL
TRANSCRIPTION	NULL
OF	NULL
CD44	NULL
2289	NULL
wild	NULL
type	NULL
CD44	NULL
__	NULL
mut.CD44	NULL
w-	NULL
]	NULL
competitor	NULL
none	NULL
EGR1	NULL
consensus	NULL
g	NULL
maz	NULL
Â®	NULL
x	NULL
-	NULL
&	NULL
R	NULL
*	NULL
-	NULL
8	NULL
o	NULL
g	NULL
_	NULL
``	NULL
Â®	NULL
2	NULL
Â©	NULL
2	NULL
E6r1i-	NULL
>	NULL
Â»	NULL
too	NULL
free	NULL
probe	NULL
-	NULL
Â»	NULL
1	NULL
2	NULL
3	NULL
4	NULL
500006	NULL
&	NULL
&	NULL
x	NULL
S0	NULL
&	NULL
8	NULL
&	NULL
Â§	NULL
$	NULL
&	NULL
8	NULL
8	NULL
molar	NULL
-	NULL
excess	NULL
v	NULL
~	NULL
``	NULL
v	NULL
~	NULL
v__~	NULL
to	NULL
@	NULL
to	NULL
~a	NULL
tp-	NULL
#	NULL
7	NULL
800	NULL
90	NULL
0	NULL
100	NULL
11	NULL
12	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

The	NULL
affinity	NULL
of	NULL
EGR1	NULL
for	NULL
the	NULL
nonconsensus	NULL
motif	NULL
at	NULL
bp	NULL
-301	NULL
of	NULL
the	NULL
CD44	NULL
promoter	NULL
is	NULL
lower	NULL
than	NULL
that	NULL
for	NULL
the	NULL
consensus	NULL
binding	NULL
motif	NULL
.	NULL

EMSA	NULL
were	NULL
performed	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
1F1	NULL
cells	NULL
stimulated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
and	NULL
a	NULL
Â°P-labeled	NULL
oligonucleotide	NULL
probe	NULL
containing	NULL
two	NULL
EGR1	NULL
consensus	NULL
binding	NULL
motifs	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
relative	NULL
affinity	NULL
of	NULL
EGR1	NULL
to	NULL
different	NULL
binding	NULL
motifs	NULL
,	NULL
unlabeled	NULL
oligonucleotide	NULL
competitors	NULL
containing	NULL
two	NULL
EGR1	NULL
consensus	NULL
motifs	NULL
(	NULL
lanes	NULL
3	NULL
to	NULL
6	NULL
)	NULL
or	NULL
the	NULL
nonconsensus	NULL
binding	NULL
motif	NULL
at	NULL
bp	NULL
-301	NULL
were	NULL
titrated	NULL
into	NULL
the	NULL
binding	NULL
reaction	NULL
mixtures	NULL
.	NULL

The	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
EGR1	NULL
binding	NULL
sites	NULL
for	NULL
each	NULL
competition	NULL
is	NULL
indicated	NULL
above	NULL
each	NULL
lane	NULL
.	NULL

The	NULL
competitor	NULL
used	NULL
in	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
contains	NULL
a	NULL
3-bp	NULL
mutation	NULL
in	NULL
the	NULL
bp	NULL
-301	NULL
binding	NULL
motif	NULL
.	NULL

Binding	NULL
reaction	NULL
mixtures	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide-0.5	NULL
%	NULL
TBE	NULL
gel	NULL
,	NULL
and	NULL
the	NULL
dried	NULL
gel	NULL
was	NULL
autoradiographed	NULL
.	NULL

this	NULL
motif	NULL
is	NULL
EGR1	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
,	NULL
we	NULL
inferred	NULL
that	NULL
this	NULL
complex	NULL
must	NULL
be	NULL
due	NULL
to	NULL
EGR1	NULL
.	NULL

To	NULL
formally	NULL
show	NULL
that	NULL
this	NULL
complex	NULL
was	NULL
the	NULL
result	NULL
of	NULL
EGR1	NULL
binding	NULL
rather	NULL
than	NULL
that	NULL
of	NULL
another	NULL
family	NULL
member	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
antibody	NULL
blocking	NULL
experiments	NULL
.	NULL

Antibodies	NULL
directed	NULL
to	NULL
the	NULL
unique	NULL
C	NULL
terminus	NULL
of	NULL
this	NULL
family	NULL
member	NULL
(	NULL
15	NULL
,	NULL
26	NULL
,	NULL
44	NULL
,	NULL
56	NULL
)	NULL
but	NULL
not	NULL
a	NULL
control	NULL
antiserum	NULL
(	NULL
against	NULL
CDK-4	NULL
)	NULL
specifically	NULL
blocked	NULL
formation	NULL
of	NULL
the	NULL
complex	NULL
specific	NULL
to	NULL
1F1	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
compare	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
relative	NULL
affinities	NULL
of	NULL
EGR1	NULL
for	NULL
the	NULL
bp	NULL
-301	NULL
motif	NULL
and	NULL
the	NULL
EGR1	NULL
consensus	NULL
motif	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
1F1	NULL
cells	NULL
were	NULL
again	NULL
used	NULL
as	NULL
a	NULL
source	NULL
of	NULL
cellular	NULL
EGR1	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
two	NULL
tandem	NULL
EGR1	NULL
binding	NULL
motifs	NULL
,	NULL
and	NULL
binding	NULL
was	NULL
inhibited	NULL
with	NULL
a	NULL
titration	NULL
of	NULL
cold	NULL
competitor	NULL
oligonucleotides	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
as	NULL
little	NULL
as	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
consensus	NULL
EGR1	NULL
motifs	NULL
resulted	NULL
in	NULL
a	NULL
complete	NULL
inhibition	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
lanes	NULL
3	NULL
to	NULL
6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
a	NULL
200-	NULL
to	NULL
1,000-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
nonconsensus	NULL
(	NULL
bp	NULL
-301	NULL
)	NULL
binding	NULL
site	NULL
was	NULL
necessary	NULL
to	NULL
achieve	NULL
complete	NULL
inhibition	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
compare	NULL
lanes	NULL
7	NULL
to	NULL
10	NULL
and	NULL
lanes	NULL
3	NULL
to	NULL
6	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutated	NULL
EGR1	NULL
motif	NULL
resulted	NULL
in	NULL
no	NULL
competition	NULL
,	NULL
even	NULL
at	NULL
the	NULL
higher	NULL
concentration	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
number	NULL
of	NULL
EGR1	NULL
binding	NULL
sites	NULL
needed	NULL
to	NULL
inhibit	NULL
binding	NULL
to	NULL
the	NULL
probe	NULL
,	NULL
EGR1	NULL
has	NULL
an	NULL
estimated	NULL
4-	NULL
to	NULL
10-fold-higher	NULL
binding	NULL
affinity	NULL
for	NULL
the	NULL
consensus	NULL
than	NULL
for	NULL
the	NULL
bp	NULL
-301	NULL
nonconsensus	NULL
motif	NULL
.	NULL

Expression	NULL
of	NULL
EGR1	NULL
induces	NULL
CD44	NULL
promoter	NULL
activity	NULL
.	NULL

Determination	NULL
that	NULL
EGR1	NULL
binds	NULL
to	NULL
the	NULL
bp	NULL
-301	NULL
site	NULL
on	NULL
the	NULL
CD44	NULL
gene	NULL
provided	NULL
a	NULL
mechanism	NULL
for	NULL
the	NULL
direct	NULL
interaction	NULL
of	NULL
the	NULL
EGR1	NULL
transcription	NULL
factor	NULL
and	NULL
the	NULL
CD44	NULL
promoter	NULL
.	NULL

To	NULL
directly	NULL
assess	NULL
the	NULL
role	NULL
of	NULL
EGR1	NULL
in	NULL
the	NULL
induced	NULL
transcription	NULL
of	NULL
the	NULL
CD44	NULL
gene	NULL
,	NULL
we	NULL
performed	NULL
transient	NULL
cotransfection	NULL
analysis	NULL
with	NULL
a	NULL
CD44	NULL
promoter-CAT	NULL
reporter	NULL
fusion	NULL
and	NULL
a	NULL
vector	NULL
containing	NULL
the	NULL
murine	NULL
egr-1	NULL
gene	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
B-actin	NULL
promoter	NULL
.	NULL

This	NULL
analysis	NULL
was	NULL
begun	NULL
by	NULL
using	NULL
a	NULL
reporter	NULL
construct	NULL
containing	NULL
both	NULL
the	NULL
bp	NULL
-600	NULL
and	NULL
-301	NULL
binding	NULL
sites	NULL
(	NULL
although	NULL
our	NULL
studies	NULL
discussed	NULL
above	NULL
indicate	NULL
that	NULL
the	NULL
bp	NULL
-600	NULL
site	NULL
is	NULL
unable	NULL
to	NULL
bind	NULL
EGR1	NULL
)	NULL
and	NULL
extending	NULL
3	NULL
'	NULL
through	NULL
the	NULL
CD44	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
pSacBCAT	NULL
)	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Multiple	NULL
cotransfections	NULL
with	NULL
an	NULL
egr-1	NULL
expression	NULL
vector	NULL
and	NULL
pSacBCAT	NULL
in	NULL
231.7	NULL
cells	NULL
gave	NULL
a	NULL
level	NULL
of	NULL
CAT	NULL
activity	NULL
which	NULL
was	NULL
below	NULL
the	NULL
sensitivity	NULL
of	NULL
our	NULL
assay	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
detectable	NULL
expression	NULL
was	NULL
attributed	NULL
to	NULL
a	NULL
combination	NULL
of	NULL
low	NULL
intrinsic	NULL
promoter	NULL
activity	NULL
coupled	NULL
with	NULL
,	NULL
more	NULL
importantly	NULL
,	NULL
the	NULL
low	NULL
transfection	NULL
efficiency	NULL
of	NULL
murine	NULL
B	NULL
lymphocytes	NULL
.	NULL

To	NULL
enhance	NULL
the	NULL
level	NULL
of	NULL
basal	NULL
transcription	NULL
,	NULL
the	NULL
region	NULL
spanning	NULL
bp	NULL
-701	NULL
through	NULL
-151	NULL
was	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
to	NULL
generate	NULL
pBLCD44	NULL
.	NULL

The	NULL
-701	NULL
to	NULL
-151	NULL
region	NULL
retains	NULL
both	NULL
the	NULL
bp	NULL
-600	NULL
and	NULL
-301	NULL
regions	NULL
as	NULL
well	NULL
as	NULL
the	NULL
two	NULL
Sp1	NULL
binding	NULL
sites	NULL
and	NULL
the	NULL
API	NULL
site	NULL
but	NULL
does	NULL
not	NULL
include	NULL
the	NULL
putative	NULL
endogenous	NULL
CD44	NULL
transcription	NULL
initiation	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
)	NULL
.	NULL

Because	NULL
we	NULL
were	NULL
using	NULL
a	NULL
human	NULL
promoter	NULL
construct	NULL
in	NULL
murine	NULL
cells	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
both	NULL
human	NULL
EGR1	NULL
and	NULL
murine	NULL
EGR1	NULL
to	NULL
transactivate	NULL
the	NULL
CD44	NULL
promoter	NULL
.	NULL

Cotransfection	NULL
of	NULL
pBLCD44	NULL
with	NULL
an	NULL
expression	NULL
vector	NULL
for	NULL
the	NULL
murine	NULL
EGR1	NULL
(	NULL
pAC-mEGR1	NULL
)	NULL
or	NULL
the	NULL
human	NULL
EGR1	NULL
(	NULL
pAC-hEGR1	NULL
)	NULL
resulted	NULL
in	NULL
5-	NULL
and	NULL
7-fold	NULL
inductions	NULL
of	NULL
CAT	NULL
activity	NULL
,	NULL
respectively	NULL
,	NULL
compared	NULL
with	NULL
that	NULL
for	NULL
the	NULL
empty	NULL
expression	NULL
vector	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
.	NULL

In	NULL
a	NULL
subsequent	NULL
experiment	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
bp	NULL
-301	NULL
site	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

10A	NULL
)	NULL
was	NULL
shown	NULL
to	NULL
abolish	NULL
the	NULL
ability	NULL
of	NULL
EGR1	NULL
to	NULL
transactivate	NULL
the	NULL
transfected	NULL
CD44	NULL
promoter-CAT	NULL
construct	NULL
.	NULL

In	NULL
this	NULL
experiment	NULL
,	NULL
transfection	NULL
of	NULL
the	NULL
wild-type	NULL
CD44-CAT	NULL
reporter	NULL
with	NULL
pAC-hEGR1	NULL
resulted	NULL
in	NULL
a	NULL
2-fold	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
in	NULL
231.7	NULL
cells	NULL
,	NULL
while	NULL
the	NULL
same	NULL
reporter	NULL
with	NULL
a	NULL
mutated	NULL
bp	NULL
-301	NULL
EGR1	NULL
binding	NULL
site	NULL
exhibited	NULL
no	NULL
induction	NULL
(	NULL
1.1-fold	NULL
)	NULL
.	NULL

Although	NULL
inducible	NULL
activity	NULL
was	NULL
relatively	NULL
low	NULL
in	NULL
this	NULL
experiment	NULL
,	NULL
the	NULL
results	NULL
clearly	NULL
establish	NULL
the	NULL
necessity	NULL
for	NULL
the	NULL
integrity	NULL
of	NULL
this	NULL
site	NULL
for	NULL
EGR1	NULL
transactivation	NULL
.	NULL

These	NULL
results	NULL
,	NULL
together	NULL
with	NULL
DNA	NULL
binding	NULL
data	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
indicate	NULL
that	NULL
EGR1	NULL
binding	NULL
to	NULL
the	NULL
CD44	NULL
promoter	NULL
at	NULL
bp	NULL
-301	NULL
results	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
CD44	NULL
transcription	NULL
.	NULL

2290	NULL
MALTZMAN	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

hsvTK-	NULL
TATA	NULL
m	NULL
anc	NULL
.	NULL

O	NULL
sPp-1	NULL
pac	NULL
.	NULL

heer	NULL
W	NULL
Ir	NULL
pace	NULL
meek	NULL
WII	NULL
pAC	NULL
0	NULL
2	NULL
4	NULL
6	NULL
8	NULL
10	NULL
Relative	NULL
CAT	NULL
activity	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

EGR1	NULL
transactivates	NULL
a	NULL
CD44	NULL
reporter	NULL
construct	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
CD44	NULL
promoter-CAT	NULL
reporter	NULL
construct	NULL
.	NULL

A	NULL
550-bp	NULL
region	NULL
of	NULL
the	NULL
CD44	NULL
promoter	NULL
was	NULL
cloned	NULL
immediately	NULL
5	NULL
of	NULL
a	NULL
minimal	NULL
herpes	NULL
simplex	NULL
virus-thymidine	NULL
kinase	NULL
(	NULL
hsvTK	NULL
)	NULL
promoter	NULL
driving	NULL
a	NULL
CAT	NULL
reporter	NULL
gene	NULL
.	NULL

The	NULL
EGR1	NULL
binding	NULL
site	NULL
is	NULL
at	NULL
bp	NULL
-301	NULL
.	NULL

(	NULL
B	NULL
)	NULL
231.7	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
20	NULL
mg	NULL
of	NULL
pBLCD44	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
expression	NULL
vectors	NULL
for	NULL
either	NULL
human	NULL
EGR1	NULL
(	NULL
pAC-hEGR1	NULL
)	NULL
,	NULL
murine	NULL
EGR1	NULL
(	NULL
pAC-mEGR1	NULL
)	NULL
,	NULL
or	NULL
no	NULL
insert	NULL
(	NULL
pAC	NULL
)	NULL
.	NULL

Ten	NULL
micrograms	NULL
of	NULL
pSV	NULL
,	NULL
PAP	NULL
was	NULL
included	NULL
to	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Amounts	NULL
of	NULL
acetylated	NULL
and	NULL
nonacetylated	NULL
chloramphenicol	NULL
were	NULL
measured	NULL
from	NULL
thin-layer	NULL
chromatography	NULL
plates	NULL
by	NULL
PhosphorImager	NULL
analysis	NULL
,	NULL
and	NULL
percent	NULL
conversion	NULL
was	NULL
calculated	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

All	NULL
values	NULL
were	NULL
corrected	NULL
for	NULL
transfection	NULL
efficiency	NULL
by	NULL
using	NULL
placental	NULL
alkaline	NULL
phosphatase	NULL
activity	NULL
.	NULL

The	NULL
EGR1	NULL
binding	NULL
motif	NULL
at	NULL
bp	NULL
-301	NULL
of	NULL
the	NULL
CD44	NULL
promoter	NULL
is	NULL
necessary	NULL
for	NULL
full	NULL
transcriptional	NULL
induction	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
the	NULL
EGR1	NULL
binding	NULL
motif	NULL
during	NULL
stimulus-induced	NULL
transcription	NULL
of	NULL
CD44	NULL
was	NULL
assessed	NULL
by	NULL
introducing	NULL
a	NULL
3-bp	NULL
mutation	NULL
into	NULL
the	NULL
bp	NULL
-301	NULL
motif	NULL
in	NULL
pBLCD44	NULL
(	NULL
Fig	NULL
.	NULL

10A	NULL
)	NULL
.	NULL

The	NULL
mutated	NULL
motif	NULL
retained	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
Sp1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
but	NULL
no	NULL
longer	NULL
bound	NULL
EGR1	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
.	NULL

The	NULL
two	NULL
CD44	NULL
report-ers	NULL
,	NULL
pBLCD44	NULL
and	NULL
the	NULL
mutated	NULL
pBLmCD44	NULL
,	NULL
were	NULL
used	NULL
in	NULL
transient	NULL
transfection	NULL
experiments	NULL
in	NULL
primary	NULL
,	NULL
nontransformed	NULL
B	NULL
lymphocytes	NULL
previously	NULL
stimulated	NULL
with	NULL
LPS	NULL
for	NULL
72	NULL
h	NULL
to	NULL
increase	NULL
transfection	NULL
efficiently	NULL
(	NULL
37	NULL
)	NULL
.	NULL

This	NULL
system	NULL
was	NULL
necessary	NULL
for	NULL
these	NULL
studies	NULL
because	NULL
stimulation	NULL
of	NULL
EGR1-expressing	NULL
1F1	NULL
cells	NULL
results	NULL
in	NULL
cell	NULL
cycle	NULL
arrest	NULL
and	NULL
apoptosis	NULL
at	NULL
24	NULL
h	NULL
,	NULL
contra-indicating	NULL
its	NULL
use	NULL
in	NULL
a	NULL
24-h	NULL
CAT	NULL
assay	NULL
.	NULL

However	NULL
,	NULL
even	NULL
more	NULL
important	NULL
,	NULL
the	NULL
use	NULL
of	NULL
LPS-pretreated	NULL
cells	NULL
allowed	NULL
the	NULL
investigation	NULL
of	NULL
EGR1	NULL
regulation	NULL
of	NULL
the	NULL
CD44	NULL
promoter	NULL
in	NULL
a	NULL
nontransformed	NULL
B-cell	NULL
population	NULL
at	NULL
physiological	NULL
levels	NULL
of	NULL
endogenous	NULL
EGR1	NULL
protein	NULL
.	NULL

Although	NULL
basal	NULL
levels	NULL
of	NULL
CD44	NULL
mRNA	NULL
were	NULL
higher	NULL
in	NULL
these	NULL
cells	NULL
than	NULL
in	NULL
unstimulated	NULL
B	NULL
lymphocytes	NULL
,	NULL
stimulation	NULL
with	NULL
either	NULL
PMA	NULL
or	NULL
BCR	NULL
cross-linking	NULL
nonetheless	NULL
induced	NULL
increased	NULL
message	NULL
levels	NULL
of	NULL
CD44	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
increased	NULL
(	NULL
3.3-fold	NULL
)	NULL
when	NULL
LPS-pretreated	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pBLCD44	NULL
and	NULL
stimulated	NULL
with	NULL
PMA	NULL
for	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

10B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
stimulation	NULL
of	NULL
pBLmCD44	NULL
transfected	NULL
cells	NULL
resulted	NULL
in	NULL
only	NULL
minimal	NULL
(	NULL
1.1-fold	NULL
)	NULL
and	NULL
insignificant	NULL
(	NULL
P	NULL
<	NULL
0.01	NULL
)	NULL
induction	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
an	NULL
intact	NULL
EGR1	NULL
binding	NULL
motif	NULL
,	NULL
therefore	NULL
,	NULL
was	NULL
necessary	NULL
for	NULL
full	NULL
transcriptional	NULL
induction	NULL
of	NULL
this	NULL
gene	NULL
when	NULL
physiological	NULL
levels	NULL
of	NULL
EGR1	NULL
were	NULL
mediating	NULL
this	NULL
response	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
apparent	NULL
complete	NULL
abrogation	NULL
of	NULL
transcriptional	NULL
induction	NULL
by	NULL
mutation	NULL
of	NULL
the	NULL
EGR1	NULL
binding	NULL
site	NULL
argues	NULL
that	NULL
other	NULL
potential	NULL
transcription	NULL
factors	NULL
that	NULL
may	NULL
be	NULL
induced	NULL
by	NULL
stimulation	NULL
of	NULL
these	NULL
cells	NULL
play	NULL
insignificant	NULL
roles	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
this	NULL
promoter	NULL
under	NULL
these	NULL
conditions	NULL
.	NULL

DISCUSSION	NULL
Stimulation	NULL
of	NULL
B	NULL
lymphocytes	NULL
through	NULL
the	NULL
BCR	NULL
initiates	NULL
a	NULL
set	NULL
of	NULL
second-messenger	NULL
pathways	NULL
leading	NULL
to	NULL
the	NULL
rapid	NULL
and	NULL
transient	NULL
induction	NULL
of	NULL
immediate-early	NULL
genes	NULL
,	NULL
many	NULL
of	NULL
which	NULL
encode	NULL
transcription	NULL
factors	NULL
(	NULL
28	NULL
,	NULL
39	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Through	NULL
their	NULL
ability	NULL
to	NULL
regulate	NULL
expression	NULL
of	NULL
stimulus-	NULL
and	NULL
tissue-specific	NULL
genes	NULL
,	NULL
the	NULL
protein	NULL
products	NULL
of	NULL
these	NULL
genes	NULL
are	NULL
believed	NULL
to	NULL
function	NULL
to	NULL
translate	NULL
these	NULL
second-messenger	NULL
pathways	NULL
into	NULL
the	NULL
alterations	NULL
of	NULL
phenotype	NULL
and	NULL
activation	NULL
state	NULL
that	NULL
accompany	NULL
specific	NULL
cellular	NULL
responses	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
target	NULL
genes	NULL
for	NULL
proteins	NULL
encoded	NULL
by	NULL
specific	NULL
immediate-early	NULL
genes	NULL
is	NULL
an	NULL
approach	NULL
to	NULL
understanding	NULL
how	NULL
BCR-induced	NULL
signals	NULL
affect	NULL
B-cell	NULL
phys-	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
EGRI-REGULATED	NULL
TRANSCRIPTION	NULL
OF	NULL
CD44	NULL
2291	NULL
A.	NULL
EGR	NULL
1	NULL
GCGGGGGCAg	NULL
pBLCD44	NULL
H	NULL
or	NULL
``	NULL
L	NULL
I	NULL
Ar-	NULL
:	NULL
gggGCGGGTCTAg	NULL
pBLmCD44	NULL
O	NULL
sp-1	NULL
SP	NULL
1	NULL
f	NULL
I	NULL
}	NULL
|	NULL
Q	NULL
I	NULL
hsvTk-	NULL
TATA	NULL
CAT	NULL
-701	NULL
-600	NULL
_	NULL
-500	NULL
_	NULL
-400	NULL
_	NULL
-300	NULL
B.	NULL
pBLmCD44	NULL
W	NULL
|	NULL
0	NULL
1	NULL
Â«	NULL
-L.	NULL
3	NULL
4	NULL
CAT	NULL
activity	NULL
(	NULL
fold	NULL
induction	NULL
)	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

The	NULL
EGR1	NULL
binding	NULL
motif	NULL
at	NULL
bp	NULL
-301	NULL
is	NULL
necessary	NULL
for	NULL
PMA-induced	NULL
CD44	NULL
transcription	NULL
in	NULL
nontransformed	NULL
lymphocytes	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
CD44	NULL
promoter	NULL
constructs	NULL
used	NULL
in	NULL
panel	NULL
B.	NULL
pBLCD44	NULL
and	NULL
pBLmCD44	NULL
differ	NULL
by	NULL
the	NULL
indicated	NULL
3-bp	NULL
mutation	NULL
which	NULL
abolishes	NULL
EGR1	NULL
binding	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Forty	NULL
micrograms	NULL
of	NULL
pBLCD44	NULL
or	NULL
the	NULL
mutant	NULL
reporter	NULL
pBLmCD44	NULL
were	NULL
transfected	NULL
into	NULL
5	NULL
%	NULL
10	NULL
``	NULL
LPS-pretreated	NULL
B	NULL
lymphocytes	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Twenty-four	NULL
hours	NULL
following	NULL
transfection	NULL
,	NULL
the	NULL
cultures	NULL
were	NULL
evenly	NULL
divided	NULL
and	NULL
either	NULL
stimulated	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
or	NULL
left	NULL
unstimulated	NULL
.	NULL

Following	NULL
an	NULL
additional	NULL
24	NULL
h	NULL
of	NULL
incubation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

The	NULL
results	NULL
depict	NULL
the	NULL
mean	NULL
fold	NULL
induction	NULL
(	NULL
compared	NULL
with	NULL
unstimulated	NULL
cells	NULL
)	NULL
from	NULL
five	NULL
independent	NULL
experiments	NULL
+	NULL
the	NULL
standard	NULL
error	NULL
of	NULL
the	NULL
mean	NULL
.	NULL

iology	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
the	NULL
CD44	NULL
gene	NULL
as	NULL
a	NULL
target	NULL
of	NULL
EGR1	NULL
regulation	NULL
in	NULL
antigen	NULL
receptor-stimulated	NULL
B	NULL
lymphocytes	NULL
.	NULL

This	NULL
finding	NULL
provides	NULL
insight	NULL
into	NULL
a	NULL
key	NULL
element	NULL
,	NULL
allowing	NULL
us	NULL
to	NULL
trace	NULL
BCR-initiated	NULL
signaling	NULL
pathways	NULL
to	NULL
a	NULL
defined	NULL
B-cell	NULL
pheno-typic	NULL
change	NULL
that	NULL
is	NULL
relevant	NULL
to	NULL
its	NULL
participation	NULL
in	NULL
an	NULL
immune	NULL
response	NULL
.	NULL

Our	NULL
evidence	NULL
for	NULL
EGR1	NULL
regulation	NULL
of	NULL
CD44	NULL
expression	NULL
is	NULL
based	NULL
upon	NULL
an	NULL
experimental	NULL
system	NULL
which	NULL
allows	NULL
comparisons	NULL
of	NULL
gene	NULL
regulation	NULL
in	NULL
subclones	NULL
of	NULL
a	NULL
single	NULL
B-cell	NULL
line	NULL
.	NULL

To	NULL
the	NULL
extent	NULL
that	NULL
we	NULL
have	NULL
been	NULL
able	NULL
to	NULL
evaluate	NULL
,	NULL
these	NULL
subclones	NULL
differ	NULL
only	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
express	NULL
egr-1	NULL
.	NULL

Using	NULL
these	NULL
sub-clones	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
expression	NULL
of	NULL
EGR1	NULL
correlates	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
BCR	NULL
signaling	NULL
to	NULL
promote	NULL
induction	NULL
of	NULL
transcription	NULL
from	NULL
the	NULL
endogenous	NULL
CD44	NULL
gene	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
cells	NULL
containing	NULL
EGR1	NULL
,	NULL
but	NULL
not	NULL
those	NULL
from	NULL
cells	NULL
deficient	NULL
in	NULL
EGR1	NULL
,	NULL
have	NULL
a	NULL
binding	NULL
activity	NULL
with	NULL
an	NULL
identified	NULL
EGR1	NULL
binding	NULL
motif	NULL
in	NULL
the	NULL
CD44	NULL
promoter	NULL
.	NULL

Transient	NULL
transfection	NULL
assays	NULL
with	NULL
a	NULL
CD44	NULL
promoter-CAT	NULL
reporter	NULL
construct	NULL
definitively	NULL
show	NULL
that	NULL
EGR1	NULL
upregulates	NULL
transcription	NULL
of	NULL
the	NULL
CD44	NULL
gene	NULL
and	NULL
that	NULL
the	NULL
EGR1	NULL
binding	NULL
motif	NULL
located	NULL
at	NULL
bp	NULL
-301	NULL
is	NULL
necessary	NULL
for	NULL
full	NULL
induction	NULL
in	NULL
primary	NULL
,	NULL
nontransformed	NULL
B-cell	NULL
blasts	NULL
.	NULL

The	NULL
transient	NULL
transfections	NULL
described	NULL
in	NULL
this	NULL
report	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
using	NULL
a	NULL
chimeric	NULL
reporter	NULL
in	NULL
which	NULL
the	NULL
5	NULL
``	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
CD44	NULL
gene	NULL
regulated	NULL
transcription	NULL
from	NULL
a	NULL
minimal	NULL
promoter	NULL
containing	NULL
the	NULL
heterologous	NULL
herpes	NULL
simplex	NULL
virus-thymidine	NULL
kinase	NULL
TATA	NULL
box	NULL
as	NULL
a	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Multiple	NULL
transfection	NULL
experiments	NULL
using	NULL
a	NULL
reporter	NULL
(	NULL
pSacBCAT	NULL
)	NULL
which	NULL
uses	NULL
the	NULL
CD44	NULL
transcription	NULL
start	NULL
site	NULL
resulted	NULL
in	NULL
no	NULL
detectable	NULL
CAT	NULL
activity	NULL
with	NULL
either	NULL
231.7	NULL
or	NULL
LPS-pretreated	NULL
B	NULL
lymphocytes	NULL
even	NULL
though	NULL
this	NULL
promoter	NULL
is	NULL
active	NULL
in	NULL
murine	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
33a	NULL
)	NULL
.	NULL

We	NULL
believe	NULL
that	NULL
a	NULL
combination	NULL
of	NULL
the	NULL
low	NULL
transfection	NULL
efficiency	NULL
of	NULL
B	NULL
lymphocytes	NULL
and	NULL
the	NULL
low	NULL
promoter	NULL
activity	NULL
results	NULL
in	NULL
transcriptional	NULL
activity	NULL
below	NULL
the	NULL
level	NULL
of	NULL
detection	NULL
with	NULL
our	NULL
assay	NULL
.	NULL

Chimeric	NULL
reporters	NULL
with	NULL
promoter	NULL
fragments	NULL
driving	NULL
heterologous	NULL
promoters	NULL
are	NULL
commonly	NULL
used	NULL
to	NULL
investigate	NULL
gene	NULL
regulation	NULL
.	NULL

We	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
regulation	NULL
of	NULL
the	NULL
chimeric	NULL
pBLCD44	NULL
reporter	NULL
is	NULL
different	NULL
from	NULL
either	NULL
that	NULL
of	NULL
pSacBCAT	NULL
or	NULL
that	NULL
of	NULL
the	NULL
endogenous	NULL
CD44	NULL
gene	NULL
;	NULL
however	NULL
,	NULL
the	NULL
data	NULL
obtained	NULL
from	NULL
transient	NULL
transfections	NULL
of	NULL
pBLCD44	NULL
complement	NULL
our	NULL
studies	NULL
with	NULL
the	NULL
WEHI-231	NULL
subclones	NULL
in	NULL
which	NULL
regulation	NULL
is	NULL
mediated	NULL
through	NULL
the	NULL
normal	NULL
CD44	NULL
promoter	NULL
in	NULL
its	NULL
relevant	NULL
chromosomal	NULL
con-text	NULL
.	NULL

In	NULL
the	NULL
WEHI-231	NULL
system	NULL
,	NULL
PMA-induced	NULL
transcription	NULL
and	NULL
anti-p	NULL
antibody-induced	NULL
transcription	NULL
from	NULL
the	NULL
endogenous	NULL
CD44	NULL
promoter	NULL
are	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
EGR1	NULL
.	NULL

In	NULL
cells	NULL
that	NULL
lack	NULL
EGR1	NULL
(	NULL
231.7	NULL
)	NULL
,	NULL
a	NULL
minimal	NULL
increase	NULL
in	NULL
transcription	NULL
was	NULL
observed	NULL
following	NULL
stimulation	NULL
.	NULL

Similarly	NULL
,	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
promoter	NULL
construct	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
intact	NULL
EGR1	NULL
binding	NULL
site	NULL
(	NULL
pBLCD44	NULL
versus	NULL
pBLmCD44	NULL
,	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
anti-p	NULL
antibody-induced	NULL
transcription	NULL
and	NULL
PMA-induced	NULL
transcription	NULL
of	NULL
CD44	NULL
require	NULL
an	NULL
interaction	NULL
between	NULL
EGR1	NULL
and	NULL
the	NULL
EGR1	NULL
binding	NULL
site	NULL
at	NULL
bp	NULL
-301	NULL
of	NULL
the	NULL
promoter	NULL
.	NULL

Identification	NULL
of	NULL
EGR1	NULL
target	NULL
genes	NULL
has	NULL
been	NULL
limited	NULL
to	NULL
date	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
identification	NULL
of	NULL
a	NULL
small	NULL
number	NULL
of	NULL
large-ly	NULL
,	NULL
but	NULL
not	NULL
exclusively	NULL
,	NULL
tissue-specific	NULL
genes	NULL
(	NULL
1	NULL
,	NULL
20	NULL
,	NULL
33	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Many	NULL
of	NULL
these	NULL
EGR1-regulated	NULL
genes	NULL
are	NULL
rich	NULL
in	NULL
G+C	NULL
content	NULL
and	NULL
lack	NULL
2292	NULL
MALTZMAN	NULL
ET	NULL
AL	NULL
.	NULL

the	NULL
TATA	NULL
and	NULL
CCAAT	NULL
elements	NULL
classically	NULL
found	NULL
in	NULL
eukary-otic	NULL
promoters	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
human	NULL
CD44	NULL
promoter	NULL
lacks	NULL
both	NULL
TATA	NULL
and	NULL
CCAAT	NULL
elements	NULL
,	NULL
and	NULL
the	NULL
region	NULL
between	NULL
bp	NULL
+1	NULL
and	NULL
-701	NULL
(	NULL
investigated	NULL
in	NULL
this	NULL
report	NULL
)	NULL
contains	NULL
approximately	NULL
65	NULL
%	NULL
G+C	NULL
(	NULL
57	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
contains	NULL
three	NULL
Sp1	NULL
sites	NULL
and	NULL
two	NULL
EGR	NULL
1-like	NULL
motifs	NULL
within	NULL
1	NULL
kb	NULL
of	NULL
the	NULL
start	NULL
site	NULL
;	NULL
EGR1	NULL
binds	NULL
detectably	NULL
only	NULL
to	NULL
the	NULL
bp	NULL
-301	NULL
site	NULL
.	NULL

The	NULL
9-bp	NULL
consensus	NULL
binding	NULL
motif	NULL
for	NULL
EGR1	NULL
was	NULL
originally	NULL
identified	NULL
mainly	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
experiments	NULL
using	NULL
bacterially	NULL
expressed	NULL
or	NULL
in	NULL
vitro-translated	NULL
EGR1	NULL
protein	NULL
,	NULL
often	NULL
not	NULL
utilizing	NULL
the	NULL
entire	NULL
coding	NULL
sequence	NULL
(	NULL
7	NULL
,	NULL
12	NULL
,	NULL
48	NULL
)	NULL
.	NULL

More	NULL
recently	NULL
,	NULL
a	NULL
systematic	NULL
PCR-based	NULL
approach	NULL
was	NULL
taken	NULL
to	NULL
redefine	NULL
and	NULL
extend	NULL
these	NULL
studies	NULL
(	NULL
62	NULL
)	NULL
.	NULL

While	NULL
this	NULL
study	NULL
indicated	NULL
that	NULL
there	NULL
is	NULL
more	NULL
variability	NULL
in	NULL
the	NULL
binding	NULL
sequence	NULL
than	NULL
previously	NULL
appreciated	NULL
and	NULL
that	NULL
flanking	NULL
sequences	NULL
play	NULL
a	NULL
role	NULL
in	NULL
binding	NULL
site	NULL
affinity	NULL
,	NULL
it	NULL
also	NULL
utilized	NULL
bacterially	NULL
expressed	NULL
proteins	NULL
.	NULL

One	NULL
previous	NULL
study	NULL
has	NULL
addressed	NULL
the	NULL
DNA	NULL
binding	NULL
specificity	NULL
of	NULL
cellular	NULL
EGR1	NULL
(	NULL
7	NULL
)	NULL
and	NULL
showed	NULL
low-affinity	NULL
binding	NULL
of	NULL
a	NULL
cellular	NULL
factor	NULL
to	NULL
the	NULL
nonconsensus	NULL
motif	NULL
found	NULL
at	NULL
bp	NULL
-279	NULL
of	NULL
the	NULL
egr-1	NULL
promoter	NULL
(	NULL
which	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
nonamer	NULL
at	NULL
bp	NULL
-301	NULL
of	NULL
the	NULL
CD44	NULL
promoter	NULL
)	NULL
.	NULL

This	NULL
factor	NULL
was	NULL
not	NULL
conclusively	NULL
shown	NULL
to	NULL
be	NULL
EGR1	NULL
and	NULL
may	NULL
have	NULL
been	NULL
a	NULL
related	NULL
family	NULL
member	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
binding	NULL
of	NULL
mammalian	NULL
EGR1	NULL
to	NULL
the	NULL
nonconsensus	NULL
motif	NULL
located	NULL
at	NULL
bp	NULL
-301	NULL
by	NULL
using	NULL
a	NULL
combination	NULL
of	NULL
nuclear	NULL
extracts	NULL
that	NULL
differ	NULL
in	NULL
respect	NULL
to	NULL
EGR1	NULL
and	NULL
antibody	NULL
blocking	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
consistent	NULL
with	NULL
findings	NULL
obtained	NULL
with	NULL
synthetic	NULL
EGR1	NULL
protein	NULL
(	NULL
6	NULL
)	NULL
,	NULL
the	NULL
affinity	NULL
of	NULL
EGR1	NULL
for	NULL
this	NULL
motif	NULL
is	NULL
lower	NULL
than	NULL
that	NULL
for	NULL
the	NULL
consensus	NULL
EGR1	NULL
binding	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

The	NULL
low	NULL
affinity	NULL
of	NULL
EGR1	NULL
for	NULL
this	NULL
site	NULL
may	NULL
affect	NULL
competition	NULL
between	NULL
EGR1	NULL
and	NULL
Spl	NULL
for	NULL
binding	NULL
to	NULL
this	NULL
motif	NULL
.	NULL

Overlapping	NULL
EGR1-Spl1	NULL
binding	NULL
motifs	NULL
are	NULL
common	NULL
in	NULL
EGR1-regulated	NULL
genes	NULL
,	NULL
and	NULL
competition	NULL
of	NULL
these	NULL
factors	NULL
for	NULL
the	NULL
site	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
regulation	NULL
of	NULL
some	NULL
of	NULL
these	NULL
(	NULL
1	NULL
,	NULL
16	NULL
)	NULL
.	NULL

We	NULL
have	NULL
not	NULL
formally	NULL
addressed	NULL
competition	NULL
between	NULL
these	NULL
two	NULL
factors	NULL
for	NULL
this	NULL
motif	NULL
.	NULL

The	NULL
Sp1	NULL
sites	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
functionally	NULL
significant	NULL
in	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
in	NULL
neuroblastoma	NULL
cells	NULL
(	NULL
57	NULL
)	NULL
.	NULL

While	NULL
data	NULL
do	NULL
not	NULL
support	NULL
a	NULL
role	NULL
for	NULL
Sp1	NULL
in	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
CD44	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
Sp1	NULL
is	NULL
important	NULL
for	NULL
basal	NULL
expression	NULL
of	NULL
CD44	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
possibility	NULL
are	NULL
the	NULL
observations	NULL
that	NULL
Sp1	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
nearly	NULL
all	NULL
cell	NULL
types	NULL
(	NULL
14	NULL
,	NULL
52	NULL
)	NULL
and	NULL
that	NULL
previous	NULL
studies	NULL
implicating	NULL
a	NULL
role	NULL
for	NULL
Sp1	NULL
in	NULL
CD44	NULL
regulation	NULL
(	NULL
57	NULL
)	NULL
have	NULL
only	NULL
evaluated	NULL
noninducible	NULL
expression	NULL
.	NULL

Previous	NULL
studies	NULL
of	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
CD44	NULL
in	NULL
cloned	NULL
embryo	NULL
rat	NULL
fibroblast	NULL
cells	NULL
have	NULL
implicated	NULL
the	NULL
API	NULL
site	NULL
in	NULL
ras-dependent	NULL
induction	NULL
of	NULL
CD44	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Although	NULL
our	NULL
studies	NULL
do	NULL
not	NULL
specifically	NULL
address	NULL
the	NULL
importance	NULL
of	NULL
this	NULL
site	NULL
in	NULL
B	NULL
lymphocytes	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
there	NULL
is	NULL
little	NULL
if	NULL
any	NULL
stimula-tion-dependent	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
from	NULL
pBLCD44	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
EGR-1	NULL
binding	NULL
in	NULL
primary	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

10B	NULL
)	NULL
.	NULL

This	NULL
does	NULL
not	NULL
rule	NULL
out	NULL
a	NULL
role	NULL
for	NULL
API	NULL
in	NULL
B-lymphocyte	NULL
regulation	NULL
of	NULL
CD44	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
AP1	NULL
and	NULL
EGR1	NULL
are	NULL
both	NULL
necessary	NULL
for	NULL
optimal	NULL
transcription	NULL
and	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
either	NULL
transcription	NULL
factor	NULL
results	NULL
in	NULL
a	NULL
reduction	NULL
in	NULL
transcription	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
here	NULL
that	NULL
we	NULL
do	NULL
not	NULL
consistently	NULL
observe	NULL
a	NULL
difference	NULL
in	NULL
CD44	NULL
inducibility	NULL
in	NULL
anti-p	NULL
antibody-stimulated	NULL
splenic	NULL
B	NULL
cells	NULL
from	NULL
normal	NULL
and	NULL
EGR1-deficient	NULL
mice	NULL
(	NULL
29	NULL
)	NULL
.	NULL

However	NULL
,	NULL
given	NULL
that	NULL
egr-1	NULL
is	NULL
a	NULL
ubiquitously	NULL
expressed	NULL
transcription	NULL
factor	NULL
and	NULL
given	NULL
its	NULL
diverse	NULL
role	NULL
in	NULL
cellular	NULL
proliferation	NULL
and	NULL
differentiation	NULL
,	NULL
it	NULL
is	NULL
probable	NULL
that	NULL
other	NULL
family	NULL
members	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
same	NULL
sites	NULL
and	NULL
are	NULL
similarly	NULL
ubiquitously	NULL
expressed	NULL
,	NULL
such	NULL
as	NULL
egr-2	NULL
and	NULL
egr-3	NULL
,	NULL
are	NULL
likely	NULL
to	NULL
compensate	NULL
for	NULL
a	NULL
loss	NULL
in	NULL
egr-1	NULL
expression	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
egr-2	NULL
and	NULL
egr-3	NULL
are	NULL
expressed	NULL
in	NULL
murine	NULL
splenic	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

For	NULL
this	NULL
reason	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
transcription	NULL
factor	NULL
genes	NULL
belonging	NULL
to	NULL
extended	NULL
families	NULL
,	NULL
deletion	NULL
studies	NULL
with	NULL
whole	NULL
animals	NULL
targeting	NULL
single	NULL
family	NULL
members	NULL
that	NULL
affect	NULL
multiple	NULL
and	NULL
likely	NULL
essential	NULL
devel-	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

opmental	NULL
and	NULL
physiological	NULL
processes	NULL
are	NULL
unlikely	NULL
to	NULL
be	NULL
defin-itive	NULL
,	NULL
given	NULL
the	NULL
enormous	NULL
selective	NULL
pressure	NULL
for	NULL
compensation	NULL
to	NULL
ensure	NULL
viable	NULL
offspring	NULL
.	NULL

In	NULL
the	NULL
specific	NULL
case	NULL
discussed	NULL
here	NULL
,	NULL
perhaps	NULL
a	NULL
better	NULL
approach	NULL
would	NULL
be	NULL
to	NULL
use	NULL
the	NULL
recombinase	NULL
gene-defective	NULL
mouse	NULL
system	NULL
so	NULL
that	NULL
the	NULL
targeted	NULL
gene	NULL
could	NULL
be	NULL
restricted	NULL
to	NULL
cells	NULL
of	NULL
the	NULL
T	NULL
and	NULL
B	NULL
lineages	NULL
.	NULL

However	NULL
,	NULL
even	NULL
potential	NULL
effects	NULL
on	NULL
cell	NULL
development	NULL
could	NULL
complicate	NULL
these	NULL
studies	NULL
.	NULL

CD44	NULL
has	NULL
been	NULL
hypothesized	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
both	NULL
physiological	NULL
and	NULL
pathologic	NULL
cellular	NULL
migration	NULL
and	NULL
trafficking	NULL
.	NULL

Several	NULL
tumor	NULL
models	NULL
have	NULL
implicated	NULL
splice	NULL
variants	NULL
of	NULL
CD44	NULL
in	NULL
increased	NULL
metastatic	NULL
potential	NULL
(	NULL
24	NULL
,	NULL
50	NULL
)	NULL
.	NULL

In	NULL
nontransformed	NULL
lymphocytes	NULL
,	NULL
CD44	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
lymphocyte	NULL
extrav-asation	NULL
into	NULL
secondary	NULL
lymphoid	NULL
tissue	NULL
(	NULL
58	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
,	NULL
cell	NULL
adhesion	NULL
models	NULL
have	NULL
demonstrated	NULL
that	NULL
CD44	NULL
is	NULL
the	NULL
primary	NULL
cell	NULL
surface	NULL
receptor	NULL
for	NULL
HA	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
stimulation	NULL
of	NULL
B	NULL
lymphocytes	NULL
leads	NULL
to	NULL
the	NULL
increased	NULL
expression	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cell	NULL
surface	NULL
proteins	NULL
,	NULL
including	NULL
CD44	NULL
,	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
lymphocyte	NULL
homing	NULL
and	NULL
migration	NULL
.	NULL

CD44	NULL
protein	NULL
levels	NULL
are	NULL
increased	NULL
within	NULL
24	NULL
h	NULL
following	NULL
stimulation	NULL
through	NULL
the	NULL
BCR	NULL
on	NULL
primary	NULL
cells	NULL
(	NULL
5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
relationship	NULL
of	NULL
B-lymphocyte	NULL
CD44	NULL
surface	NULL
levels	NULL
and	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
HA	NULL
is	NULL
complex	NULL
.	NULL

Differences	NULL
in	NULL
N	NULL
glycosylation	NULL
of	NULL
newly	NULL
synthesized	NULL
CD44	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
HA	NULL
(	NULL
22	NULL
,	NULL
27	NULL
,	NULL
32	NULL
)	NULL
.	NULL

While	NULL
a	NULL
signal	NULL
through	NULL
the	NULL
BCR	NULL
complex	NULL
is	NULL
sufficient	NULL
to	NULL
increase	NULL
the	NULL
density	NULL
of	NULL
surface	NULL
CD44	NULL
on	NULL
B	NULL
lymphocytes	NULL
,	NULL
affinity	NULL
for	NULL
HA	NULL
does	NULL
not	NULL
increase	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
additional	NULL
signals	NULL
such	NULL
as	NULL
the	NULL
presence	NULL
of	NULL
interleukin-5	NULL
(	NULL
15	NULL
,	NULL
22	NULL
,	NULL
26	NULL
,	NULL
47	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Activated	NULL
B	NULL
lymphocytes	NULL
,	NULL
with	NULL
high	NULL
levels	NULL
of	NULL
CD44	NULL
transcription	NULL
,	NULL
could	NULL
receive	NULL
this	NULL
additional	NULL
signal	NULL
upon	NULL
entering	NULL
the	NULL
appropriate	NULL
secondary	NULL
lymphoid	NULL
tissue	NULL
and	NULL
begin	NULL
expressing	NULL
modified	NULL
(	NULL
HA-binding	NULL
)	NULL
CD44	NULL
.	NULL

Both	NULL
increased	NULL
transcription	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
the	NULL
result	NULL
of	NULL
BCR	NULL
cross-linking	NULL
)	NULL
and	NULL
an	NULL
alteration	NULL
in	NULL
the	NULL
posttranslational	NULL
milieu	NULL
of	NULL
the	NULL
cell	NULL
(	NULL
due	NULL
to	NULL
an	NULL
interleukin-5	NULL
signal	NULL
)	NULL
would	NULL
be	NULL
necessary	NULL
to	NULL
allow	NULL
increased	NULL
HA	NULL
binding	NULL
and	NULL
retention	NULL
in	NULL
the	NULL
lymphoid	NULL
tissue	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
results	NULL
presented	NULL
in	NULL
this	NULL
paper	NULL
offer	NULL
evidence	NULL
of	NULL
a	NULL
linkage	NULL
between	NULL
BCR-induced	NULL
biochemical	NULL
changes	NULL
and	NULL
downstream	NULL
alterations	NULL
in	NULL
B-lymphocyte	NULL
phenotype	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
EGR1	NULL
participates	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
numerous	NULL
other	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
B-lymphocyte	NULL
activation	NULL
response	NULL
.	NULL

It	NULL
is	NULL
perhaps	NULL
interesting	NULL
that	NULL
we	NULL
have	NULL
recently	NULL
identified	NULL
another	NULL
EGR1	NULL
target	NULL
gene	NULL
in	NULL
BCR-stimulated	NULL
B	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
.	NULL

This	NULL
gene	NULL
,	NULL
Icam-1	NULL
,	NULL
like	NULL
the	NULL
CD44	NULL
gene	NULL
,	NULL
encodes	NULL
an	NULL
adhesion	NULL
molecule	NULL
involved	NULL
in	NULL
the	NULL
B-cell-mediated	NULL
immune	NULL
response	NULL
.	NULL

This	NULL
suggests	NULL
the	NULL
possibility	NULL
that	NULL
EGR1	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
coordinate	NULL
regulation	NULL
of	NULL
cellular	NULL
interaction	NULL
proteins	NULL
involved	NULL
in	NULL
early	NULL
phases	NULL
of	NULL
the	NULL
humoral	NULL
immune	NULL
response	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Marian	NULL
Birkeland	NULL
and	NULL
Amanda	NULL
Norvell	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
NIH	NULL
grants	NULL
AI-23568	NULL
and	NULL
AI-32592	NULL
.	NULL

J.S.M	NULL
.	NULL

was	NULL
partially	NULL
supported	NULL
by	NULL
NIH	NULL
Medical	NULL
Scientist	NULL
Training	NULL
Program	NULL
Grant	NULL
5-T32-GM-07170	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Ackerman	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
A.	NULL
G.	NULL
Minden	NULL
,	NULL
G.	NULL
T.	NULL
Williams	NULL
,	NULL
C.	NULL
Bobonis	NULL
,	NULL
and	NULL
C.	NULL
Y.	NULL
Yeung	NULL
.	NULL

1991	NULL
.	NULL

Functional	NULL
significance	NULL
of	NULL
an	NULL
overlapping	NULL
consensus	NULL
binding	NULL
motif	NULL
for	NULL
Sp1	NULL
and	NULL
Zif268	NULL
in	NULL
the	NULL
murine	NULL
adenosine	NULL
deaminase	NULL
gene	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:7523-7527	NULL
.	NULL

2	NULL
.	NULL

Aruffo	NULL
,	NULL
A.	NULL
,	NULL
I	NULL
Stamenkovic	NULL
,	NULL
M.	NULL
Melnick	NULL
,	NULL
C.	NULL
B.	NULL
Underhill	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Seed	NULL
.	NULL

1990	NULL
.	NULL

CD44	NULL
is	NULL
the	NULL
principal	NULL
cell	NULL
surface	NULL
receptor	NULL
for	NULL
hyaluronate	NULL
.	NULL

Cell	NULL
61:1303-1313	NULL
.	NULL

3	NULL
.	NULL

Benhamou	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
P.-A	NULL
.	NULL

Cazenave	NULL
,	NULL
and	NULL
P.	NULL
Sarthou	NULL
.	NULL

1990	NULL
.	NULL

Anti-immunoglobu-lins	NULL
induce	NULL
death	NULL
by	NULL
apoptosis	NULL
in	NULL
WEHI-231	NULL
B	NULL
lymphoma	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

20:1405-1407	NULL
.	NULL

4	NULL
.	NULL

Cambier	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
C.	NULL
M.	NULL
Pleiman	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Clark	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transduction	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28.	NULL
by	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
and	NULL
its	NULL
coreceptors	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12	NULL
:	NULL
457-486.	NULL
.	NULL

Camp	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
T.	NULL
A.	NULL
Kraus	NULL
,	NULL
M.	NULL
L.	NULL
Birkeland	NULL
,	NULL
and	NULL
E.	NULL
PurÃ©	NULL
.	NULL

1991	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
CD44	NULL
expression	NULL
distinguish	NULL
virgin	NULL
from	NULL
antigen-primed	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

173:763-766.	NULL
.	NULL

Cao	NULL
,	NULL
X.	NULL
,	NULL
R.	NULL
A.	NULL
Koski	NULL
,	NULL
A.	NULL
Gashler	NULL
,	NULL
M.	NULL
McKiernan	NULL
,	NULL
C.	NULL
F.	NULL
Morris	NULL
,	NULL
R.	NULL
Gaffney	NULL
,	NULL
R.	NULL
V.	NULL
Hay	NULL
,	NULL
and	NULL
V.	NULL
P.	NULL
Sukhatme	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
Egr-1	NULL
gene	NULL
product	NULL
,	NULL
a	NULL
DNA-binding	NULL
zinc	NULL
finger	NULL
protein	NULL
induced	NULL
by	NULL
differentiation	NULL
and	NULL
growth	NULL
signals	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:1931-1939.	NULL
.	NULL

Cao	NULL
,	NULL
X.	NULL
,	NULL
R.	NULL
Mahendran	NULL
,	NULL
G.	NULL
R.	NULL
Guy	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Tan	NULL
.	NULL

1993	NULL
.	NULL

Detection	NULL
and	NULL
characterization	NULL
of	NULL
cellular	NULL
EGR1	NULL
binding	NULL
to	NULL
its	NULL
recognition	NULL
site	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:16949-16957.	NULL
.	NULL

Carman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
Monroe	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
EGR1	NULL
protein	NULL
contains	NULL
a	NULL
discrete	NULL
transcriptional	NULL
regulatory	NULL
domain	NULL
whose	NULL
deletion	NULL
results	NULL
in	NULL
a	NULL
truncated	NULL
protein	NULL
that	NULL
blocks	NULL
EGR1-induced	NULL
transcription	NULL
.	NULL

DNA	NULL
Cell	NULL
Biol	NULL
.	NULL

14	NULL
:	NULL
581-589.	NULL
.	NULL

Celano	NULL
,	NULL
P.	NULL
,	NULL
C.	NULL
Berchtold	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
J.	NULL
Casero	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
simplification	NULL
of	NULL
the	NULL
nuclear	NULL
run-off	NULL
transcription	NULL
assay	NULL
.	NULL

BioTechniques	NULL
7:942-944	NULL
.	NULL

Chiles	NULL
,	NULL
T.	NULL
C	NULL
,	NULL
,	NULL
J.	NULL
Liu	NULL
,	NULL
and	NULL
T.	NULL
L.	NULL
Rothstein	NULL
.	NULL

1991	NULL
.	NULL

Cross-linking	NULL
of	NULL
surface	NULL
Ig	NULL
receptors	NULL
on	NULL
murine	NULL
B	NULL
lymphocytes	NULL
stimulates	NULL
the	NULL
expression	NULL
of	NULL
nuclear	NULL
tetradecanoyl	NULL
phorbol	NULL
acetate-response	NULL
element-binding	NULL
proteins	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:1730-1735	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
N.	NULL
Sacchi	NULL
.	NULL

1987	NULL
.	NULL

Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Bio-chem	NULL
.	NULL

162:156	NULL
.	NULL

Christy	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
D.	NULL
Nathans	NULL
.	NULL

1989	NULL
.	NULL

DNA	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
growth	NULL
factor-inducible	NULL
protein	NULL
Zif268	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:8737-8741	NULL
.	NULL

Christy	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
L.	NULL
F.	NULL
Lau	NULL
,	NULL
and	NULL
D.	NULL
Nathans	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
gene	NULL
activated	NULL
in	NULL
mouse	NULL
3T3	NULL
cells	NULL
by	NULL
serum	NULL
growth	NULL
factors	NULL
encodes	NULL
a	NULL
protein	NULL
with	NULL
``	NULL
zinc	NULL
finger	NULL
``	NULL
sequences	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:7857-7861	NULL
.	NULL

Courey	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1988	NULL
.	NULL

Analysis	NULL
of	NULL
Sp1	NULL
in	NULL
vivo	NULL
reveals	NULL
multiple	NULL
transcriptional	NULL
domains	NULL
,	NULL
including	NULL
a	NULL
novel	NULL
glutamine-rich	NULL
activation	NULL
motif	NULL
.	NULL

Cell	NULL
55:887-898	NULL
.	NULL

Crosby	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
R.	NULL
A.	NULL
Veile	NULL
,	NULL
H.	NULL
Donis-Keller	NULL
,	NULL
J.	NULL
M.	NULL
Baraban	NULL
,	NULL
R.	NULL
V.	NULL
Bhat	NULL
,	NULL
K.	NULL
S.	NULL
Simburger	NULL
,	NULL
and	NULL
J.	NULL
Milbrandt	NULL
.	NULL

1992	NULL
.	NULL

Neural-specific	NULL
expression	NULL
,	NULL
genomic	NULL
structure	NULL
,	NULL
and	NULL
chromosomal	NULL
localization	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
zinc-finger	NULL
transcription	NULL
factor	NULL
NGFI-C.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:4739-4743	NULL
.	NULL

Ebert	NULL
,	NULL
S.	NULL
N.	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Wong	NULL
.	NULL

1995	NULL
.	NULL

Differential	NULL
activation	NULL
of	NULL
the	NULL
rat	NULL
phenyl-ethanolamine	NULL
N-methyltransferase	NULL
gene	NULL
by	NULL
Sp1	NULL
and	NULL
EGR1	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:17299-17305	NULL
.	NULL

Gashler	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
S.	NULL
Swaminathan	NULL
,	NULL
and	NULL
V.	NULL
P.	NULL
Sukhatme	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
novel	NULL
repression	NULL
module	NULL
,	NULL
an	NULL
extensive	NULL
activation	NULL
domain	NULL
,	NULL
and	NULL
a	NULL
bipartite	NULL
nuclear	NULL
localization	NULL
signal	NULL
defined	NULL
in	NULL
the	NULL
immediate-early	NULL
transcription	NULL
factor	NULL
Egr-1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4556-4571	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
L.	NULL
F.	NULL
Moffat	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Howard	NULL
.	NULL

1982	NULL
.	NULL

Recombinant	NULL
genomes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyltransferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

21044-1051	NULL
.	NULL

Gunning	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
Leavitt	NULL
,	NULL
G.	NULL
Muscat	NULL
,	NULL
S.	NULL
Y.	NULL
Ng	NULL
,	NULL
and	NULL
L.	NULL
Kedes	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
human	NULL
B-actin	NULL
expression	NULL
vector	NULL
system	NULL
directs	NULL
high-level	NULL
accumulation	NULL
of	NULL
antisense	NULL
transcripts	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:4831-4835	NULL
.	NULL

Gupta	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
M.	NULL
Gupta	NULL
,	NULL
R.	NULL
Zak	NULL
,	NULL
and	NULL
V.	NULL
P.	NULL
Sukhatme	NULL
.	NULL

1991	NULL
.	NULL

Egr-1	NULL
,	NULL
a	NULL
serum-inducible	NULL
zinc	NULL
finger	NULL
protein	NULL
,	NULL
regulates	NULL
transcription	NULL
of	NULL
the	NULL
rat	NULL
cardiac	NULL
e-myosin	NULL
heavy	NULL
chain	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:12813-12816	NULL
.	NULL

Hasbold	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
G.	NULL
G.	NULL
B.	NULL
Klaus	NULL
.	NULL

1990	NULL
.	NULL

Anti-immunoglobulin	NULL
antibodies	NULL
induce	NULL
apoptosis	NULL
in	NULL
immature	NULL
B	NULL
cell	NULL
lymphomas	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

20:1685-1690	NULL
.	NULL

Hathcock	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
H.	NULL
Hirano	NULL
,	NULL
S.	NULL
Murakami	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Hodes	NULL
.	NULL

1993	NULL
.	NULL

CD44	NULL
expression	NULL
on	NULL
activated	NULL
B	NULL
cells	NULL
.	NULL

Differential	NULL
capacity	NULL
for	NULL
CD44-dependent	NULL
binding	NULL
to	NULL
hyaluronic	NULL
acid	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:6712-6722	NULL
.	NULL

Henthorn	NULL
,	NULL
P.	NULL
,	NULL
P.	NULL
Zervos	NULL
,	NULL
M.	NULL
Raducha	NULL
,	NULL
H.	NULL
Harris	NULL
,	NULL
and	NULL
T.	NULL
Kadesch	NULL
.	NULL

1988	NULL
.	NULL

Expression	NULL
of	NULL
a	NULL
human	NULL
placental	NULL
alkaline	NULL
phosphatase	NULL
gene	NULL
in	NULL
transfected	NULL
cells	NULL
:	NULL
use	NULL
as	NULL
a	NULL
reporter	NULL
for	NULL
studies	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:6342-6346	NULL
.	NULL

Hofmann	NULL
,	NULL
M.	NULL
,	NULL
W.	NULL
Rudy	NULL
,	NULL
U.	NULL
Gunthert	NULL
,	NULL
S.	NULL
G.	NULL
Zimmer	NULL
,	NULL
V.	NULL
Zawadzki	NULL
,	NULL
M.	NULL
Zoller	NULL
,	NULL
R.	NULL
B.	NULL
Lichtner	NULL
,	NULL
P.	NULL
Herrlich	NULL
,	NULL
and	NULL
H.	NULL
Ponta	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
link	NULL
between	NULL
ras	NULL
and	NULL
metastatic	NULL
behavior	NULL
of	NULL
tumor	NULL
cells	NULL
:	NULL
ras	NULL
induces	NULL
CD44	NULL
promoter	NULL
activity	NULL
and	NULL
leads	NULL
to	NULL
low-level	NULL
expression	NULL
of	NULL
metastasis-specific	NULL
variants	NULL
of	NULL
CD44	NULL
in	NULL
CREF	NULL
cells	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

53:1516-1521	NULL
.	NULL

Horton	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Z.	NULL
Cai	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
and	NULL
L.	NULL
R.	NULL
Pease	NULL
.	NULL

1990	NULL
.	NULL

Gene	NULL
splicing	NULL
by	NULL
overlap	NULL
extension	NULL
:	NULL
tailor-made	NULL
genes	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

BioTechniques	NULL
8:528-535	NULL
.	NULL

Joseph	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
M.	NULL
M.	NULL
Le	NULL
Beau	NULL
,	NULL
G.	NULL
A.	NULL
Jamieson	NULL
,	NULL
Jr.	NULL
,	NULL
S.	NULL
Acharya	NULL
,	NULL
T.	NULL
B	NULL
.	NULL

Shows	NULL
,	NULL
J.	NULL
D.	NULL
Rowley	NULL
,	NULL
and	NULL
V.	NULL
P.	NULL
Sukhatme	NULL
.	NULL

1988	NULL
.	NULL

Molecular	NULL
cloning	NULL
,	NULL
sequencing	NULL
,	NULL
and	NULL
mapping	NULL
of	NULL
EGR2	NULL
,	NULL
a	NULL
human	NULL
early	NULL
growth	NULL
response	NULL
gene	NULL
encoding	NULL
a	NULL
protein	NULL
with	NULL
zinc-binding	NULL
finger	NULL
structure	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:7164-7168	NULL
.	NULL

(	NULL
Erratum	NULL
,	NULL
86:5-15	NULL
,	NULL
1989	NULL
.	NULL
)	NULL

Katoh	NULL
,	NULL
S.	NULL
,	NULL
Z.	NULL
Zheng	NULL
,	NULL
K.	NULL
Oritani	NULL
,	NULL
T.	NULL
Shimozato	NULL
,	NULL
and	NULL
P.	NULL
W.	NULL
Kincade	NULL
.	NULL

1995	NULL
.	NULL

Glycosylation	NULL
of	NULL
CD44	NULL
negatively	NULL
regulates	NULL
its	NULL
recognition	NULL
of	NULL
hyaluronan	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:419-429	NULL
.	NULL

Klemsz	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
L.	NULL
B.	NULL
Justement	NULL
,	NULL
E.	NULL
Palmer	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Cambier	NULL
.	NULL

1989	NULL
.	NULL

Induction	NULL
of	NULL
c-fos	NULL
and	NULL
c-myc	NULL
expression	NULL
during	NULL
B	NULL
cell	NULL
activation	NULL
by	NULL
IL-4	NULL
and	NULL
immunoglobulin	NULL
binding	NULL
ligands	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143:1032-1039	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

EGRI-REGULATED	NULL
TRANSCRIPTION	NULL
OF	NULL
CD44	NULL
2293	NULL
Lee	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
L.	NULL
C.	NULL
Tourtellotte	NULL
,	NULL
R.	NULL
L.	NULL
Wesselschmidt	NULL
,	NULL
and	NULL
J.	NULL
Milbrandt	NULL
.	NULL

1995	NULL
.	NULL

Growth	NULL
and	NULL
differentiation	NULL
proceeds	NULL
normally	NULL
in	NULL
cells	NULL
deficient	NULL
in	NULL
the	NULL
immediate	NULL
carly	NULL
gene	NULL
NGF1-A	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:9971-9977	NULL
.	NULL

Lemaire	NULL
,	NULL
P.	NULL
,	NULL
O.	NULL
Revelant	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
and	NULL
P.	NULL
Charnay	NULL
.	NULL

1988	NULL
.	NULL

Two	NULL
mouse	NULL
genes	NULL
encoding	NULL
potential	NULL
transcription	NULL
factors	NULL
with	NULL
identical	NULL
DNA-binding	NULL
domains	NULL
are	NULL
activated	NULL
by	NULL
growth	NULL
factors	NULL
in	NULL
cultured	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:4691-4695	NULL
.	NULL

Lemaire	NULL
,	NULL
P.	NULL
,	NULL
C.	NULL
Vesque	NULL
,	NULL
J.	NULL
Schmitt	NULL
,	NULL
H.	NULL
Stunnenberg	NULL
,	NULL
R.	NULL
Frank	NULL
,	NULL
and	NULL
P.	NULL
Charnay	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
serum-inducible	NULL
mouse	NULL
gene	NULL
Krox-24	NULL
encodes	NULL
a	NULL
se-quence-specific	NULL
transcriptional	NULL
activator	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:3456-3467	NULL
.	NULL

Lesley	NULL
,	NULL
J.	NULL
,	NULL
A.	NULL
English	NULL
,	NULL
J.	NULL
Perschl	NULL
,	NULL
J.	NULL
Gregoroff	NULL
,	NULL
and	NULL
R.	NULL
Hyman	NULL
.	NULL

1995	NULL
.	NULL

Variant	NULL
cell	NULL
lines	NULL
selected	NULL
for	NULL
alterations	NULL
in	NULL
the	NULL
function	NULL
of	NULL
the	NULL
hyaluronan	NULL
receptor	NULL
CD44	NULL
show	NULL
differences	NULL
in	NULL
glycosylation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:431-437	NULL
.	NULL

Li	NULL
,	NULL
Y.	NULL
,	NULL
S.	NULL
Camp	NULL
,	NULL
T.	NULL
L.	NULL
Rachinsky	NULL
,	NULL
C.	NULL
Bongiorno	NULL
,	NULL
and	NULL
P.	NULL
Taylor	NULL
.	NULL

1993	NULL
.	NULL

Promoter	NULL
elements	NULL
and	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
mouse	NULL
acetylcholinester-ase	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:3563-3572	NULL
.	NULL

33a.Maltzman	NULL
,	NULL
J.	NULL
S.	NULL
Unpublished	NULL
results	NULL
.	NULL

34	NULL
.	NULL

Maltzman	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Carman	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
Monroe	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
Icam-1	NULL
gene	NULL
in	NULL
antigen	NULL
receptor	NULL
and	NULL
phorbol	NULL
ester	NULL
stimulated	NULL
B	NULL
lymphocytes	NULL
:	NULL
role	NULL
for	NULL
transcription	NULL
factor	NULL
EGR1	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

34a.Maltzman	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Wan	NULL
,	NULL
and	NULL
J.	NULL
Monroe	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

McMahon	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
Monroe	NULL
.	NULL

1992	NULL
.	NULL

Role	NULL
of	NULL
primary	NULL
response	NULL
genes	NULL
in	NULL
generating	NULL
cellular	NULL
responses	NULL
to	NULL
growth	NULL
factors	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

62707-2715	NULL
.	NULL

McMahon	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
Monroe	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
p21ras	NULL
pathway	NULL
couples	NULL
antigen	NULL
receptor	NULL
stimulation	NULL
to	NULL
induction	NULL
of	NULL
the	NULL
primary	NULL
response	NULL
gene	NULL
egr-1	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:417-422	NULL
.	NULL

McMahon	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
A.	NULL
Norvell	NULL
,	NULL
K.	NULL
J.	NULL
Levine	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
Monroe	NULL
.	NULL

1995	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
murine	NULL
B	NULL
lymphocyte	NULL
blasts	NULL
as	NULL
a	NULL
method	NULL
for	NULL
examining	NULL
gene	NULL
regulation	NULL
in	NULL
primary	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
179:251-259	NULL
.	NULL

Milbrandt	NULL
,	NULL
J	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
nerve	NULL
growth	NULL
factor-induced	NULL
gene	NULL
encodes	NULL
a	NULL
possible	NULL
transcriptional	NULL
regulatory	NULL
factor	NULL
.	NULL

Science	NULL
238:797-799	NULL
.	NULL

Mittelstadt	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
A.	NULL
L.	NULL
DeFranco	NULL
.	NULL

1993	NULL
.	NULL

Induction	NULL
of	NULL
early	NULL
response	NULL
genes	NULL
by	NULL
cross-linking	NULL
membrane	NULL
Ig	NULL
on	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150	NULL
:	NULL
4822-4832	NULL
.	NULL

Miyaka	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
B.	NULL
Underhill	NULL
,	NULL
J.	NULL
Lesley	NULL
,	NULL
and	NULL
P.	NULL
W.	NULL
Kincade	NULL
.	NULL

1990	NULL
.	NULL

Hyaluronate	NULL
can	NULL
function	NULL
as	NULL
a	NULL
cell	NULL
adhesion	NULL
molecule	NULL
and	NULL
CD44	NULL
participates	NULL
in	NULL
hyaluronate	NULL
recognition	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:69-75	NULL
.	NULL

Molnar	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Crozat	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Pardee	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
immediate-early	NULL
gene	NULL
Egr-1	NULL
regulates	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
at	NULL
the	NULL
Gy-to-G1	NULL
transition	NULL
of	NULL
the	NULL
cell	NULL
cyele	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:5242-5248	NULL
.	NULL

Monroe	NULL
,	NULL
J.	NULL
G.	NULL
1988	NULL
.	NULL

Up-regulation	NULL
of	NULL
c-fos	NULL
expression	NULL
is	NULL
a	NULL
component	NULL
of	NULL
the	NULL
mig	NULL
signal	NULL
transduction	NULL
mechanism	NULL
but	NULL
is	NULL
not	NULL
indicative	NULL
of	NULL
competence	NULL
for	NULL
proliferation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140:1454	NULL
.	NULL

Monroe	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
A.	NULL
J.	NULL
Yellen-Shaw	NULL
,	NULL
and	NULL
V.	NULL
L.	NULL
Seyfert	NULL
.	NULL

1993	NULL
.	NULL

Molecular	NULL
basis	NULL
for	NULL
unresponsiveness	NULL
and	NULL
tolerance	NULL
induction	NULL
in	NULL
immature	NULL
stage	NULL
B	NULL
lymphocytes	NULL
.	NULL

Adv	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

1:1-32	NULL
.	NULL

Murakami	NULL
,	NULL
S.	NULL
,	NULL
K.	NULL
Miyake	NULL
,	NULL
P.	NULL
W.	NULL
Kincade	NULL
,	NULL
and	NULL
R.	NULL
J.	NULL
Hodes	NULL
.	NULL

1991	NULL
.	NULL

Functional	NULL
role	NULL
of	NULL
CD44	NULL
(	NULL
Pgp-1	NULL
)	NULL
on	NULL
activated	NULL
B	NULL
cells	NULL
.	NULL

Immunol	NULL
.	NULL

Res	NULL
.	NULL

10:15-27	NULL
.	NULL

Nakache	NULL
,	NULL
M.	NULL
,	NULL
E.	NULL
L.	NULL
Berg	NULL
,	NULL
P.	NULL
R.	NULL
Streeter	NULL
,	NULL
and	NULL
E.	NULL
C.	NULL
Butcher	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
mucosal	NULL
vascular	NULL
addressin	NULL
is	NULL
a	NULL
tissue-specific	NULL
endothelial	NULL
cell	NULL
adhesion	NULL
molecule	NULL
for	NULL
circulating	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
337:179-191	NULL
.	NULL

Nguyen	NULL
,	NULL
H.	NULL
,	NULL
B.	NULL
Hoffman-Liebermann	NULL
,	NULL
and	NULL
D.	NULL
Liebermann	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
zinc	NULL
finger	NULL
transcription	NULL
factor	NULL
egr-1	NULL
is	NULL
essential	NULL
for	NULL
and	NULL
restricts	NULL
differentiation	NULL
along	NULL
the	NULL
macrophage	NULL
lineage	NULL
.	NULL

Cell	NULL
72:197-209	NULL
.	NULL

Patwardhan	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Gashler	NULL
,	NULL
M.	NULL
G.	NULL
Siegel	NULL
,	NULL
L.	NULL
C.	NULL
Chang	NULL
,	NULL
L.	NULL
J.	NULL
Joseph	NULL
,	NULL
T.	NULL
B	NULL
.	NULL

Shows	NULL
,	NULL
M.	NULL
M.	NULL
LeBeau	NULL
,	NULL
and	NULL
V.	NULL
P.	NULL
Sukhatme	NULL
.	NULL

1991	NULL
.	NULL

EGR3	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
Egr	NULL
family	NULL
of	NULL
genes	NULL
encoding	NULL
immediate-early	NULL
transcription	NULL
factors	NULL
.	NULL

Oncogene	NULL
6:917-928	NULL
.	NULL

Pavletich	NULL
,	NULL
N.	NULL
P.	NULL
,	NULL
and	NULL
C.	NULL
O.	NULL
Pabo	NULL
.	NULL

1991	NULL
.	NULL

Zinc	NULL
finger-DNA	NULL
recognition	NULL
:	NULL
crystal	NULL
structure	NULL
of	NULL
a	NULL
Zif268-DNA	NULL
complex	NULL
at	NULL
2.1	NULL
A	NULL
.	NULL

Science	NULL
252:809-817	NULL
.	NULL

Pospelov	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
T.	NULL
V.	NULL
Pospelova	NULL
,	NULL
and	NULL
J.	NULL
Julien	NULL
.	NULL

1994	NULL
.	NULL

AP-1	NULL
and	NULL
Krox-24	NULL
transcription	NULL
factors	NULL
activate	NULL
the	NULL
neurofilament	NULL
light	NULL
gene	NULL
promoter	NULL
in	NULL
P19	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

5:187-196	NULL
.	NULL

Rudy	NULL
,	NULL
W.	NULL
,	NULL
M.	NULL
Hofmann	NULL
,	NULL
R.	NULL
Schwartz-Albiez	NULL
,	NULL
M.	NULL
Zoller	NULL
,	NULL
K.	NULL
H.	NULL
Heider	NULL
,	NULL
H.	NULL
Ponta	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
two	NULL
major	NULL
CD44	NULL
proteins	NULL
expressed	NULL
on	NULL
a	NULL
metastatic	NULL
rat	NULL
tumor	NULL
cell	NULL
line	NULL
are	NULL
derived	NULL
from	NULL
different	NULL
splice	NULL
variants	NULL
:	NULL
cach	NULL
one	NULL
individually	NULL
suffices	NULL
to	NULL
confer	NULL
metastatic	NULL
behavior	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

53:1262-1268	NULL
.	NULL

Russo	NULL
,	NULL
M.	NULL
W.	NULL
,	NULL
C.	NULL
Matheny	NULL
,	NULL
and	NULL
J.	NULL
Milbrandt	NULL
.	NULL

1993	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
the	NULL
zinc	NULL
finger	NULL
protein	NULL
NGFI-A	NULL
is	NULL
influenced	NULL
by	NULL
its	NULL
interaction	NULL
with	NULL
a	NULL
cellular	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:6858-6865	NULL
.	NULL

Saffer	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
S.	NULL
P.	NULL
Jackson	NULL
,	NULL
and	NULL
M.	NULL
B.	NULL
Annarella	NULL
.	NULL

1991	NULL
.	NULL

Developmental	NULL
expression	NULL
of	NULL
Sp1	NULL
in	NULL
the	NULL
mouse	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:2189-2199	NULL
.	NULL

Scott	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
D.	NULL
Livnat	NULL
,	NULL
C.	NULL
A.	NULL
Pennell	NULL
,	NULL
and	NULL
P.	NULL
Keng	NULL
.	NULL

1986	NULL
.	NULL

Lymphoma	NULL
models	NULL
for	NULL
B	NULL
cell	NULL
activation	NULL
and	NULL
tolerance	NULL
.	NULL

III	NULL
.	NULL

Cell	NULL
cycle	NULL
dependence	NULL
for	NULL
negative	NULL
signalling	NULL
of	NULL
WEHI-231	NULL
B	NULL
lymphoma	NULL
cells	NULL
by	NULL
anti-p.	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

164:156-164	NULL
.	NULL

Screaton	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
M.	NULL
V.	NULL
Bell	NULL
,	NULL
D.	NULL
G.	NULL
Jackson	NULL
,	NULL
F.	NULL
B.	NULL
Cornelis	NULL
,	NULL
U.	NULL
Gerth	NULL
,	NULL
and	NULL
J.	NULL
I	NULL
.	NULL

Bell	NULL
.	NULL

1992	NULL
.	NULL

Genomic	NULL
structure	NULL
of	NULL
DNA	NULL
encoding	NULL
the	NULL
lymphocyte	NULL
homing	NULL
receptor	NULL
CD44	NULL
reveals	NULL
at	NULL
least	NULL
12	NULL
alternatively	NULL
spliced	NULL
exons	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:12160-12164	NULL
.	NULL

Seyfert	NULL
,	NULL
V.	NULL
L.	NULL
,	NULL
S.	NULL
McMahon	NULL
,	NULL
W.	NULL
Glenn	NULL
,	NULL
X.	NULL
Cao	NULL
,	NULL
V.	NULL
P.	NULL
Sukhatme	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
2294	NULL
56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

MALTZMAN	NULL
ET	NULL
AL	NULL
.	NULL

Monroe	NULL
.	NULL

1990	NULL
.	NULL

Egr-1	NULL
expression	NULL
in	NULL
surface	NULL
Ig-mediated	NULL
B	NULL
cell	NULL
activation	NULL
.	NULL

Kinetics	NULL
and	NULL
association	NULL
with	NULL
protein	NULL
kinase	NULL
C	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145	NULL
:	NULL
3647-3653	NULL
.	NULL

Seyfert	NULL
,	NULL
V.	NULL
L.	NULL
,	NULL
S.	NULL
B.	NULL
McMahon	NULL
,	NULL
W.	NULL
D.	NULL
Glenn	NULL
,	NULL
A.	NULL
J.	NULL
Yellen	NULL
,	NULL
V.	NULL
P.	NULL
Sukhatme	NULL
,	NULL
X.	NULL
Cao	NULL
,	NULL
and	NULL
J.	NULL
G.	NULL
Monroe	NULL
.	NULL

1990	NULL
.	NULL

Methylation	NULL
of	NULL
an	NULL
immediate-early	NULL
inducible	NULL
gene	NULL
as	NULL
a	NULL
mechanism	NULL
for	NULL
B	NULL
cell	NULL
tolerance	NULL
induction	NULL
.	NULL

Science	NULL
250:797-800	NULL
.	NULL

Shtivelman	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Bishop	NULL
.	NULL

1991	NULL
.	NULL

Expression	NULL
of	NULL
CD44	NULL
is	NULL
repressed	NULL
in	NULL
neuroblastoma	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:5446-5453	NULL
.	NULL

Streeter	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
E.	NULL
L.	NULL
Berg	NULL
,	NULL
B.	NULL
T.	NULL
N.	NULL
Rouse	NULL
,	NULL
R.	NULL
F.	NULL
Bargatze	NULL
,	NULL
and	NULL
E.	NULL
C.	NULL
Butcher	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
tissue-specific	NULL
endothelial	NULL
cell	NULL
molecule	NULL
involved	NULL
in	NULL
lymphocyte	NULL
homing	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
331:41-46	NULL
.	NULL

Suggs	NULL
,	NULL
S.	NULL
V.	NULL
,	NULL
J.	NULL
L.	NULL
Katzowitz	NULL
,	NULL
C.	NULL
Tsai-Morris	NULL
,	NULL
and	NULL
V.	NULL
P.	NULL
Sukhatme	NULL
.	NULL

1990.	NULL
cDNA	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
cellular	NULL
early	NULL
growth	NULL
response	NULL
gene	NULL
Egr-1	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:4283	NULL
.	NULL

Sukhatme	NULL
,	NULL
V.	NULL
P.	NULL
,	NULL
X.	NULL
Cao	NULL
,	NULL
L.	NULL
C.	NULL
Chang	NULL
,	NULL
C.-H.	NULL
Tsai-Morris	NULL
,	NULL
D.	NULL
Stamenkovich	NULL
,	NULL
61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

P.	NULL
C.	NULL
P.	NULL
Ferreira	NULL
,	NULL
D.	NULL
R.	NULL
Cohen	NULL
,	NULL
S.	NULL
A.	NULL
Edwards	NULL
,	NULL
T.	NULL
B	NULL
.	NULL

Shows	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
M.	NULL
M.	NULL
LeBeau	NULL
,	NULL
and	NULL
E.	NULL
D.	NULL
Adamson	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
zinc	NULL
finger-encoding	NULL
gene	NULL
co-regulated	NULL
with	NULL
c-fos	NULL
during	NULL
growth	NULL
and	NULL
differentiation	NULL
,	NULL
and	NULL
after	NULL
cellular	NULL
depolarization	NULL
.	NULL

Cell	NULL
53:37-43	NULL
.	NULL

Sukbatme	NULL
,	NULL
V.	NULL
P.	NULL
,	NULL
S.	NULL
Kartha	NULL
,	NULL
F.	NULL
G.	NULL
Toback	NULL
,	NULL
R.	NULL
Taub	NULL
,	NULL
R.	NULL
G.	NULL
Hoover	NULL
,	NULL
and	NULL
C.-H.	NULL
Tsai-Morris	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
novel	NULL
carly	NULL
growth	NULL
response	NULL
gene	NULL
rapidly	NULL
induced	NULL
by	NULL
fibroblast	NULL
,	NULL
epithelial	NULL
cell	NULL
and	NULL
lymphocyte	NULL
mitogens	NULL
.	NULL

Oncogene	NULL
Res	NULL
.	NULL

1:343-355	NULL
.	NULL

Swirnoff	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
and	NULL
J.	NULL
Milbrandt	NULL
.	NULL

1995	NULL
.	NULL

DNA-binding	NULL
specificity	NULL
of	NULL
NGFI-A	NULL
and	NULL
related	NULL
zinc	NULL
finger	NULL
transcription	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2275-2287	NULL
.	NULL

Wolffe	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
W.	NULL
C.	NULL
Gause	NULL
,	NULL
C.	NULL
M.	NULL
Pelfrey	NULL
,	NULL
S.	NULL
M.	NULL
Holland	NULL
,	NULL
A.	NULL
D.	NULL
Steinberg	NULL
,	NULL
and	NULL
J.	NULL
T.	NULL
August	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
cDNA	NULL
sequence	NULL
of	NULL
mouse	NULL
Pgp-1	NULL
and	NULL
homology	NULL
to	NULL
human	NULL
CD44	NULL
cell	NULL
surface	NULL
antigen	NULL
and	NULL
proteoglycan	NULL
core/link	NULL
proteins	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:341-347.	NULL
.	NULL

Xie	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
C.	NULL
Chiles	NULL
,	NULL
and	NULL
T.	NULL
L.	NULL
Rothstein	NULL
.	NULL

1993	NULL
.	NULL

Induction	NULL
of	NULL
CREB	NULL
activity	NULL
via	NULL
the	NULL
surface	NULL
Ig	NULL
receptor	NULL
of	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:880-889	NULL
.	NULL

